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Abstract
Azaspiracids (AZAs) are a family of lipophilic polyether marine biotoxins, that have
caused a number of human intoxication incidents in Europe since 1995, which was the
first incident reported following the consumption by consumers of intoxicated
shellfish {Mytilus edulis). This class of phycotoxins has been responsible for extended
closures of shellfisheries in various locations around Europe, where levels of AZAl-3
are regulated in shellfish. Since their discovery in 1995, AZAs have become the focus
of extensive research, resulting in the discovery of numerous analogues. Only AZAl
and AZA2 have been found in phytoplankton and all the other analogues are believed
to be products of biotransformation in shellfish, mussels (M edulis). During feeding
studies that were conducted on AZA free mussels (M edulis), the suspected
biotransformation of AZAl and AZAl were confirmed and mechanism proposed.

Mussels were assimilated and depurated by keeping in 100 litre tanks assisted with an
algae suspension and supplemented with fresh sea water for up to 12 months. When
mussels were free of toxin, they were than exposed to two feeding experiments, fhese
involved administering isolated AZAl and AZA2 at a fixed concentration over a set
number of days. At the end of the feeding experiment, mussels were removed, rinsed
and dissected immediately into HP, gills and rest of tissue in order to avoid leaching
of toxin into different tissue compartments which can happen as a result of cold
storage.

Liquid Chromatography-tandem-Mass Spectrometry (LC-MS/MS) was used for AZA
analysis. It was observed that AZAl undergoes a rare C-demethylation via the
formation of a carboxylate intermediate AZA 17 to form AZA3. Since AZAl 7 is 22carboxy-AZA3, produced by oxidative metabolism of the 22-methyl of AZAl in the
mussel, this also predicted that the levels of AZA6 would also increase through an
equivalent series of transformations via AZA 19 and was the basis of isolating AZA2
and administering to live shellfish. From the AZA2 feed experiment the most likely
explanation for the observed conversion to AZA6 upon administration of AZA2 was
the presence of a thermally labile AZA6 precursor in the shellfish and their extracts,
and was observed that AZA2 undergoes C-demethylation in position C22 producing
AZA 19.

Distribution of AZAs was investigated in three of the dissected compartments of M.
edulis, (hepatopancreas (HP), gills and rest of tissue) and demonstrates that AZAs are
not solely confined to the HP as is widely accepted. In order to confirm the
distribution observed, 20 mussels, naturally contaminated with AZA, were dissected
into their individual compartments and analysed. The study showed significant levels
of AZAs in all three compartments when the mass of the tissue was taken into
account. This demonstrated the importance of extracting toxin from whole tissue, not
just from the HP, for a truer appraisal of the levels of AZA within the mussel. This
finding is of great significance in terms of procedures used in the processing of
shellfish for regulatory analysis, and it exemplifies the role of taking whole tissue and
not just HP.
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CHAPTER lA

Introduction to Phycotoxins

1.
1.1.

Phycotoxins
Introduction

Phytoplankton are microalgae and are the main contributor to the marine food web as
well as oxygen on earth. The beneficial role of algae in the food chain arises from the
fact that they are the only organisms that can readily make long chain polyunsaturated
fatty acids (PUFAs). Shellfish feed on phytoplankton and the potential beneficial role
of shellfish in the human diet has been attributed to the presence of oils that are rich in
PUFAs. Shellfish are also a rich source of protein, essential minerals, especially iron,
vitamins A and D. However, some marine microalgae are known to produce bioactive
compounds that negatively impact on human health through their accumulation in
shellfish [1,2]. Many of these toxins are known to be highly potent [3].

The proliferation of toxin-bearing algae, mainly diatoms and dinoflagellates, called
harmful algal blooms (HABs), has been a major cause of concern in recent years [4].
Bivalve molluscs filter large volumes of water when grazing on microalgae, and can
concentrate both bacterial pathogens and phycotoxins [5]. These shellfish, especially
mussels, scallops, oysters and clams, are significant vectors for toxins that are
implicated in several human toxic syndromes. The major ones are amnesic shellfish
poisoning (ASP) [6], diarrhetic shellfish poisoning (DSP) [7], paralytic shellfish
poisoning (PSP) [8], neurotoxic shellfish poisoning (NSP) [9] and azaspiracid
poisoning (AZP) [10]. Other less common seafood-poisoning toxins include
ciguatoxins [14], tetrodotoxins [15] and palytoxins [16]. ASP first came to attention in
Canada in 1987, when human fatalities occurred from eating mussels (Mytilus edulis)
[11]. Domoic acid (DA), which is produced by marine diatoms of the Pseudonitzschia spp., was identified as the causative toxic agent [12, 13]. ASP causes gastric

upset, headache and dizziness, but the syndrome was named due to the persistent
short-term memory impairment experienced by some patients [11]. Toxins produced
mainly by marine dinoflagellates are some of the most potent poisons known and
have a major impact on human health [1]. The accumulation of toxins in shellfish and
fish has led to serious human toxicosis as well as animal and bird deaths. Each of the
toxic syndromes will be discussed below, so as to be put in context with AZA. More
detailed literature regarding phycotoxins and methods for their analysis can be found
in the appendices; chapter 13, Phycotoxins.

1.2.

Poly ether Marine Toxins

1.2.1. Amnesic Shellfish Poisoning (ASP)
In 1987 more than 100 people were poisoned by what was to be known as the so
called “Prince Edward Island Disease”, after consumption of mussels that were
harvested on this eastern Canadian island. Quiliam and Wright [17] reported on big
efforts to elucidate the cause of the Prince Edward Island disease. As a result of this
intoxication, three people died and the survivors suffered memory loss. The
underlying toxin was therefore named ASP toxin (figure 1).

Although the ASP toxin DA is a water soluble compound, it possesses low toxic
potency in rodents and the mouse bioassay for PSP can only be used to detect high
DA concentrations which cause illness in humans. For that reason HPLC
methodology is used to detect DA. The Portuguese programme introduced regular
testing in late 1996, although the presence of this toxin in bivalves had already been
confirmed in 1995. The methodology used followed the same acid extraction
employed for PSP, followed by ultraviolet detection [18]. In-house studies performed

showed rapid decomposition of the toxin, and a methanolic extraction was adopted to
address this in 1999 [19]. Liquid chromatography-mass spectrometry (LC-MS) was
used to confirm the profiles previously determined by high performance liquid
chromatography-ultra violet (HPLC-UV) in plankton samples DA and isodomoic-A
were present and in bivalves isodomoic-D was also found. Specific metabolisation of
DA by bivalves does not play an important role in altering profiles, as the molecule is
known to suffer spontaneous isomerisation. Isomers represented a minor contribution
to the toxin profile and routinely were not quantified for monitoring purposes [19].
The production of DA has been associated with the occurrence of Pseudo-nitzschia
australis [20]. The duration at which ASP toxins remain in bivalve tissue is generally
quiet short when compared to that of AZA and also PSP and DSP. The explanation
derives on the behaviour of the diatoms that produce ASP. Unlike dinoflagellates that
produce AZA, DSP and PSP toxins, diatoms do not migrate so quickly.

CH

H

<

rooH
COOH

CH

Figure 1. Chemical structure of DA.

1.2.2. Diarrhetic Shellfish Poisoning (DSP)
DSP was first reported in Japan in 1978 and the illness is now recognised as a threat
to public health throughout the world. All DSP toxins are relatively nonpolar, with
molecular weights higher than 500 amu, and easily extractable by organic solvents
such as methanol and chloroform. Most DSP toxins are polyether compounds with
distinctive chemical structures and widely varying functional groups resulting in
different toxicological and chemical characteristics [21]. Marine toxins in shellfish
have been traditional categorised and regulated according to the poisoning syndromes
they evoke in human beings or animals.

For example, okadaic acid (OA) (Figure 2) and dinophysistoxins (DTXs) have been
classified as DSP toxins due to their production and symptoms of diarrhea.
Unfortunately, when pectenotoxins (PTXs) and yessotoxins (YTXs) were discovered
and before their toxicity was understood, they were placed into the DSP category
because they often occur together with OA and DTXs and were detected by the mouse
bioassay procedure first used generally to detect DSP toxins in lipophilic extracts.

With the continuing discovery of a series of new lipophilic toxins, it became clear that
a better approach would be to categorize the toxins strictly according to their chemical
classes rather that their toxic syndromes. This would allow seafood safety to be
regulated according to allowable levels of specific toxins rather that to the result of a
specific assay.

Okadaic

Acid Rj = CHs

R2 = H

R3 = H

R4

=H

R2=CH3

R3 = H

R4

=H

R2=CH3

R3 = H

R4

=H

R4

=H

(OA)
Dinophysistoxin- Ri = CH3
1 (DTX-1)
Dinophysistoxin- Ri = H
2 (DTX-2)
Dinophysistoxin- Rj^ R2 = H or Ri^ R2 = H or R3 = acyl
3 (DTX-3)

CH3

CH3

Figure 2. Chemical structures of DSP toxins OA and DTXs.

1.2.3. Paralytic Shellfish Poisoning (PSP)
Dinoflagellates are the main producers of PSP and are of the genus Alexandrium. It is
along the Atlantic and Pacific coast lines where Alexandrium occurs and which may
grow in great quantities, particularly during the summer months. Alexandrium
produced toxins that were named PSP toxins (Figure 3) due to the observation that
their consumption caused symptoms of poisoning in warm blooded species similar to
paralytic phenomena such as cramp, signs of paralyis, and blocking of respiration.
PSP toxins are potential neurotoxins which block the excitation current in the nerve
and muscle cells resulting in signs of paralysis.

PSP symptoms vary depending on the dose and the individual. In the case of a mild
intoxication, a sensation or tingling or numbness of the lips is experienced, gradually
progressing to the face and neck; pins and needles in the extremities; headache,
vertigo, nausea, vomiting and diarrhoea occur in tandem. Extreme intoxication results
in muscular paralysis, choking, and extreme respiratory difficulty often culminating in
respiratory failure [22]. Consequently the development of analytical methods for the
determination of poisoning by PSP toxins was an important task. And the
determination of PSP toxins was only possible after isolation and structural
elucidation [23].

In 1957, a PSP toxin was isolated from Saxidomiis giganteus (Clam.s) from Alaska,
and in 1975 the chemical structure was assigned to the so-called saxitoxin (STX).
More PSP toxins were later identified to which were all related to STX or N-1hydroxy-saxitoxin (neo-saxitoxin, NEO). Today, it is convenient to distinguish
between three groups of PSP toxins: carbamoyl toxins, A-sulfocarbamoyl toxins, and
decarbomyl toxins.

In 1975, a fluorometric method was recommended for PSP determination in samples
in addition to the mouse bioassay (MBA) [24]. A breakthrough in the use of HPEC
methods for PSP determination took place in 1984 when Sullivan et al [25] succeeded
in the separation of underivatised PSP toxins by ion-pair chromatography [26],
however this involved three separate isocratic runs and so was considered to be quiet
time consuming and labour intensive. Electrospray ionization mass spectrometry
(ESI-MS) is effective for detection of the polar PSP toxins, which are quiet basic and

therefore form stable [M+H]^ ions. Thus, the direct detection of underivatised PSP
toxins is possible using a mass spectrometer as detector [27].

1
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R^
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-
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H
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G1'X4

C4

deGTX4

-

Figure 3. Chemical structures of PSP toxins (STX-Saxitoxin, GTX-Gonyautoxin,
NEO-Neosaxotoxin).

1.2.4. Neurotoxic Shellfish Poisoning (NSP)
The toxins responsible for NSP have ladder like structure, the polycyclic ether toxins
are collectively called brevetoxins (PbTx). These toxins are responsible for toxicity in
marine animals, NSP in humans, and respiratory distress by inhalation of sea spray. It
has been discovered that NSP toxins act on site 5 in the sodium ion channel [28]. A
common symptom associated with exposure to aerosolised brevetoxins is respiratory
inhalation, conjunctival irritation, burning of the throat and rhinorrhea [29]. The
effects of NSP poisoning after the consumption of intoxicated shellfish are chills,
headache, diarrhoea, muscle weakness, muscle and joint pain, nausea and vomiting. In
extreme cases, altered perception of hot and cold, difficulty in breathing, double
vision, trouble in talking and swallowing may occur [22]. NSP has not been known to
be fatal and symptoms generally resolve within a few days. Brevetoxins congeners
fall into two types based on the backbone structure, the brevetoxin A (Figure 4A) and
brevetoxin B (Figure 4B). Many brevetoxins have been identified as being products of
the red tide dinoflagellate G. hreve, {Ptychodiscus brevis, formely Gymnodinum
breve) [30].

OH
R

Brevetoxin A

1^

PbTx-1

CH2C(=CH2)CH0

PbTx-7

CH2C(=CH2)CH20H

PbTx-10

CH2CH(=CH3)CH20H

Figure 4A. Chemical structure of hrevetoxin A, and analogues.

R2

Brevetoxin B

R,

R2

PbTx-2

H

CH2C(=CH2)CH0

PbTx-3

H

CH2C(=CH2)CH20H

PbTx-5

H

CH2CH(CH3)CH0

PbTx-6

CH3CO

CH2CCH2(=CH2)0H, 27, 28-epoxide

PbTx-8

H

CH2C(=CH2)C0CH2C1

PbTx-9

H

BTX-B
BTX-B]

H

_

CH2CH(=CH3)CH20H
CH2C(=CH2)CH0
CH2C(=CH2)CNHCH2CH2S03Na

Figure 4B. Chemical structure of hrevetoxin B, and analogues.

10

1.2.5. Ciguatera Toxins
The teiTn ciguatera fish poisoning (CFP) was first used in the Caribbean to describe an
intoxication induced by the ingestion of a marine snail, Turbo pica, involved in food
poisoning outbreaks during the Spanish conquest [31]. Ciguatera is a foodbome
illness caused by eating certain reef fishes whose flesh is contaminated with toxins
originally produced by dinoflageHates such as Gamhierdiscus toxicus which lives in
tropical and sub-tropical waters. These dinoflagellates adhere to coral, algae and
seaweed where they are eaten by herbivorous fish who in turn are eaten by larger
carnivorous fish. In this way the toxins move up the foodchain and bioaccumulate.
Gamhierdiscus toxicus is the primary dinoflagellate responsible for the production of
a number of sim.ilar but distinct toxins that cause ciguatera.

These toxins include ciguatoxin (Figure 5), maitotoxin, scaritoxin and palytoxin.
Predator species near the top of the food chain in tropical and sub-tropical waters,
such as barracudas, snapper, moray eels, parrotfishes, groupers, triggerfishes and
amberjacks, are most likely to cause ciguatera poisoning, although many other species
have been found to cause occasional outbreaks of toxicity. Ciguatoxin is very heatresistant, so ciguatoxin-laden fish cannot be detoxified by conventional cooking [32].
Researchers suggest that ciguatera outbreaks caused by cooling climatic conditions
propelled the migratory voyages of Polynesians between 1000 and 1400.

Due to the localised nature of the ciguatoxin-producing microorganisms, ciguatera
illness is common in only tropical waters, particularly the Pacific and Caribbean, and
usually is associated with fish caught in tropical reef waters. Ciguatoxin is found in
over 400 species of reef fish, and therefore avoidance of consumption of all reef fish

(any fish living in warm tropical waters) is the only sure way to avoid exposure to the
toxin. Imported fish served in restaurants have been found to eontain the toxin and to
produce illness whieh often goes unexplained by physicians unfamiliar with a tropical
toxin and its characteristic symptoms [33]. In addition, ciguatoxin has been found in
farm-raised salmon [34].

In 2007, ten people in St. Louis, Missouri were siekened with the disease after eating
imported fish. In February 2008, the U.S. Food and Drug Administration (FDA)
reported that several outbreaks of the disease had been traced to fish harvested near
the Flower Garden Banks National Marine Sanctuary in the northern Gulf of Mexico,
near the Texas-Louisiana shoreline. The FDA advised seafood processors that
ciguatera poisoning was "reasonably likely" to oeeur from consuming any of several
species of fish caught as far as 50 miles (80 km) from the sanctuary [35]. The
symptoms of eiguatera vary with ethnicity [36]. Currently, multiple laboratory
methods are available to deteet ciguatoxins, ineluding LCMS, receptor binding assays
(RBA), and neuroblastoma assays (N2A). Although testing is possible, in most cases
LC-MS is insufficient to deteet clinieally relevant concentrations of ciguatoxin in
crude extracts of fish.

12

HaC

OH

Figure 5. Chemical structure of ciguatera toxin.

1.2.6. Tetrodotoxins (TTX)
TTX (also known as "tetrodox") is a potent neurotoxin with no known antidote. There
have been successful tests of a possible antidote in mice, but further tests must be
carried out to determine efficacy in humans [37]. TTX blocks action potentials in
nerves by binding to the pores of the voltage-gated, fast sodium channels in nerve cell
membranes [38]. The binding site of this toxin is located at the pore opening of the
voltage-gated Na^ channel. Its name derives from Tetraodontiformes, the name of the
order that includes the pufferfish, porcupinefish, ocean sunfish or mola, and
triggerfish, several species of which carry the toxin. Although TTX (Figure 6) was
discovered in these fish and found in several other animals (e.g., Blue-ringed Octopus,
Rough-skinned newt [39], and Naticidae [40]) it is actually the product of certain
bacteria such as Pseudoalteromonas tetraodonis, certain species of Pseudomonas and
Vibrio, as well as some others. Its mechanism of action, selective block of the Na^
channel, was showed definitively in 1964 by Toshio Narahashi and John Moore at
Duke University, using Moore's sucrose gap voltage clamp technique. TTX has been
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isolated from widely differing animal species, including western newts of the genus
Taricha (where it was termed "tarichatoxin"), pufferfish, toads of the genus Atelopus,
several species of blue-ringed octopodes of the genus Hapalochlaena (where it was
called "maculotoxin"), several sea stars, an angelfish, a polyclad flatworm. The toxin
is variously used as a defensive biotoxin to ward off predation, or as both a defensive
and predatory venom (the octopodes, chaetognaths and ribbonworms). Tarichatoxin
and maculotoxin were shown to be identical to TTX in 1964 and 1978, respectively.

Recent evidence has shown the toxin to be produced by bacteria within blue-ringed
octopuses [41]. The most common source of bacteria associated with TTX production
is Vibrio bacteria, with Vibrio alginolyticus being the most common species.
Pufferfish [42], chaetognaths [43], and nemerteans [44] have been shown to contain
Vibrio alginolyticus and TTX. The toxin blocks the fast Na^ current in human
myocytes (the contractile cells of the muscles), thereby inhibiting their contraction.
By contrast, the sodium channels in pacemaker cells of the heart are of the slow
variety, so action potentials in the cardiac nodes are not inhibited by the compound.

The poisoned individual therefore dies not because the electrical activity of the heart
is compromised, but because the muscles are effectively paralysed. Blocking of fast
Na^ channels has potential medical use in treating some cardiac arrhythmias. TTX has
proved useful in the treatment of pain (originally used in Japan in the 1930s) from
such diverse problems as terminal cancer [45], migraines, and heroin withdrawal [46].
Some people even put pufferfish on their face for beauty reasons.
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©

-CHjOH

Figure 6. Chemical structure of tetrodotoxin.

1.2.7. Palytoxin
Palytoxin is a complex marine natural product containing 71 asymmetric centers.
Pal>'toxin, isolated from soft coral, is considered to be one of the most toxic non
peptide substances known, second only to maitotoxin. Palytoxin was originally
isolated in 1971 in Hawaii from the seaweed-like coral, "Limu make o hana (Seaweed
of Death from Hana)” [47]. Later, in 1982 its full chemical structure was published by
Prof. Daisuke Uemura and coworkers at Nagoya University [48-50]. Professor
Yoshito Kishi's group at Harvard University first synthesized palytoxin (Figure 7) in
1994 [51-52]. This feat is still considered today by many to be the greatest synthetic
accomplishment ever, due to its complexity in structure.
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Figure 7. Chemical structure ofpalytoxin.

1.3.

Azaspiracids (AZAs)

In 1995, there was an outbreak of human illness in the Netherlands that was
associated with ingestion of contaminated shellfish originating from Killary Harbour,
Ireland. Although the symptoms were typical of diarrhetic shellfish poisoning (DSP)
toxins such as OA and DTX, the levels of DSP toxins in these shellfish were well
below the regulatory level. Over the next two years it was established that these
shellfish were contaminated with a unique marine toxin, originally named “Killarytoxin” or KT-3 [53]. Shortly thereafter, the toxin was renamed to azaspiracid-1
(AZAl) (Figure 8), to more appropriately reflect the chemical structure of this
compound [53, 54]. Since the original azaspiracid poisoning (AZP) event, four
additional AZP events have occurred due to contaminated Irish mussels (Table 1).
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Toxin
AZAl
AZA2

R^

R'

CH3

H

H

CH3 CH3

H

H

H
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H
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H

H

OH

H
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H

H

H

OH

AZA6

CH3

H

H

H

AZAl

H

CH3 OH

AZA^

H

CH3

H

OH

AZA9

CH3

H

OH

H

AZAIO CH3

H

H

OH

AZAll CH3 CH3 OH

H

H

Figure 8. Chemical structure and the R', R~, R^ and R^ substituent’s ofAZAs.

Over the last decade, various analogues of AZA have been identified in shellfish of
many coastal regions of western Europe, as well as NW Africa [55] and Japan [125].
Extensive study of this toxin class has been constrained by limited availability of
purified material, certified reference standards of naturally produced AZAl are now
commercially available. Limits on toxin supply may be further alleviated by the
recent in vitro total synthesis of AZAl [56]. Availability of a AZA standard would
enable more rapid progress in research and improve overall understanding of AZAs.
While certain aspects of these toxins and their pharmacological effects have been
summarized previously [57-58].
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Location of Date
AZP
Netherlands

Ireland

Italy
France

United
Kingdom

Amount
consumed

Area of
production

Number of
Illnesses
recorded

Mussels
{Mytilus
edulis)
September/ Mussels
October
(M edulis)
1997

Not
recorded

Killary
Harbour,
Ireland
Arranmore
Island,
Ireland

8

September
1998
September
1998

Not
recorded
Not
recorded

Implicated
food
source

November
1995

August
2000

Mussels
(M edulis)
Scallops
(Pecten
maximus)
Frozen
mussels (M
edulis)

“As few as
10-12
mussels”

Not
recorded

Clew Bay,
Ireland
Bantry
Bay,
Ireland
Bantry
Bay,
Ireland

Estimated
20-24 (8
seen by
doctor)
10
Estimated
20-30
12-16

Table 1. Reported cases of AZA poisoning (AZP) 1995-2007 [591.

1.3.1. Occurrence of AZA s
The EU decision of 2002 for the maximum levels and the methods of analysis for
various marine biotoxins in bivalve molluscs, echinoderms, tunicates and marine
gastropods [60], establishes a limit of 0.16 mg/kg for the combined levels of AZAlAZA3, that normally comprised 95% of the total AZAs in mussels, to be determined
by LC-MS methods. However, the implementation of these regulations has been
obstructed due to the lack of reference standards necessary for implementing LC-MS
analysis but findings according to a current review by the European Food and Safety
Authority, it appears that the current European Union (EU) regulatory limit values for
AZA-group are not sufficiently protective for consumers [61].

Bulk mussel samples were subsequently collected from Killary Harbour (after the
recorded first outbreak) for detailed investigations [62] and a new group of toxins.

8

named AZAs (AZAl, KLKl and AZA3) were isolated and structurally elucidated
[63], [64]. The toxin profile in those mussel samples collected after the intoxication,
determined by LC-MS, was AZAl (1.14 pg/g), AZA2 (0.23 pg/g) and AZA3 (0.06
pg/g) [65]. Two years after the first intoxication incident in the Netherlands,
consumption of mussels cultured in Arranmore Island, County Donegal, Ireland
(Figure 9), caused gastrointestinal illness to a group of locals that recovered within 25 days. In addition to the analogues already discovered, two new analogues AZA4
and AZA5 were detected and the total toxin levels in these tissues, determined by LCMS, was higher than 30 pg/g [55], [66].

During September 1998, in Ravenna, Italy, there was a prohibition on the
consumption of local shellfish contaminated with yessotoxins. Consequently, mussels
were imported from Clew Bay, County Mayo, Ireland (Figure 9), and were
responsible for the poisoning of approximately 10 individuals. Subsequent analyses
proved that typical DSP toxins were not present at levels that could induce illness.
The HP of shellfish used for DSP protocols were retained for chemical analysis. LCMS^ revealed the presence of AZAs in these mussels at a concentration of 1 pg/g
[67].

Processed mussels harvested in 1998 from Bantry Bay, County Cork, Ireland (Figure
9), were implicated in a couple of dozen human intoxications in France. These
shellfish had been passed as “safe for human consumption” based on the regulatory
DSP mouse bioassay. However, analysis of these mussels using LC-MS methods
revealed AZA contamination that ranged between 1.1 and 1.5 pg/g in total tissue. A
study of the distribution of AZAs in the tissue compartments of mussels revealed, that

19

most of the AZAs resided in the adductor mussel segment rather than in the digestive
glands, where toxins usually accumulate [68]. The lack of confidence in regulatory
testing methods led to an embargo by France for most of 1999 of all bivalve shellfish
originating from Ireland [61]. In August 2000, shellfish poisoning occurred
throughout England, and included incidents in Sheffield, Warrington, Aylesbury and
the Isle of Wight. The suspected shellfish were processed mussels cultivated on the
southwest coast of Ireland off Bantry Bay (Figure 9).

Before export, these shellfish had passed the DSP mouse bioassay both before
harvesting and after processing [69]. AZA1-AZA3 were identified by LC-MS^
analyses as they had been used for mouse bioassays and the remaining mussel tissues
contained levels of AZAs of 0.85 pg/g. Finally, different studies carried out in the
last few years have confirmed the sporadic contamination of shellfish from many
other cultivation regions in Ireland, like Lough Foyle, Bruckless and Kenmare Bay
[69] (Figure 9).

20

/.ouf*h Foyle

Cork

Figure 9. Map of Ireland showing some of the cultivation regions where AZA
contamination of shellfish has been identified.

The Scientific Panel on Contaminants in the Food Chain has established acute
reference doses for the currently regulated marine biotoxins [61]. These are amounts
of the toxins, expressed on a body weight basis that can be consumed within 24 hours
or less without appreciable risk to health. Based on the currently available data, it
appears that the current European Union (EU) regulatory limit values for OA-group,
AZA-group, saxitoxin (STX)-group toxins and DA are not sufficiently protective for
consumers. The values for AZA can be seen in table 2.
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Toxin
Group

Current
EIJ limits
in shellfish
meat (A)

Exposure
by eating
a 400 g
portion at
the EU
limit

AZA

160 |4g aza

64 gg
eq./person
(1 Mg
AZAl
eq./kg
b.w.)

SM

Exposure by
eating a 400 g
portion at the
95"' percentile of
the
concentrations in
samples
currently on the
EU market
16 |ig eq./person
(0.3 pg AZAl
eq./kg b.w.)

ARFD

Corresponding
dose for a 60 kg
adult

Maximum
concentration
in shellfish
meat to avoid
exceeding the
ARFD when
eating a 400 g
portion (B)

Ratio

0.2 pg
AZAl
eq./kg
b.w.)

12 pg eq./person

30 pg aza
eq./kg SM

0.19

SM: Shellfish Meat, eq: equivalents, b.w.: body weight, ARFD: Acute reference dose, PSP:
paralytic shellfish poison, EU: European Union.
(c) The CONTAM panel assumed that AZA equivalent should refer to AZAl equivalents
Table 2. Current EU limits, the exposure levels resulting from consumption of
shellfish on the EU market, the acute reference doses (ARFDs) set by the European
Food Safety Authority EFSA, and the corresponding concentrations in shellfish

meat. [25]

1.3.2. Stability of AZAs and Physico-Chemical Properties
AZAl was initially reported as a colourless, odourless, amorphous solid with the
chemical formula C47H71NO12 and a molecular weight of 841.5 g/mol [70-71]. Other
studies reported the toxin to be a colourless oil [72-73]. No UV absorption maxima
were found above 210 nm wavelength and the refractive index of AZAl was
determined to be [a] 20-21 (c 0.10, MeOH). At physiological pH, AZAl exists as a
zwitterion (i.e., contains both a positive and negative charge but is electrically
neutral), which would confer detergent-like properties to this molecule [74]. This
overall neutral but potentially ionic character may result in enhanced possibilities for
interaction of AZA with its biological target. Little information is available about the

22

stability of AZAs. During the production of a tissue reference material, certain
techniques were tested to stabilise the tissue material for long-term storage.

During a heat treatment study the toxins were observed to degrade when heated over
90 °C [75]; however, the use of gamma irradiation, which is often used to stabilise
tissue reference materials, had little effect on AZA analogue stability when contained
in mussel matrix. Interestingly, the toxins were observed to undergo rapid degradation
when irradiated as a pure compound in solution [76]. AZAs stored in methanol were
shown to slowly form methyl esters of the toxin [77]. These esters were only observed
in methanol extracts stored at room temperature or higher for prolonged periods (i.e.,
several months). A similar phenomenon has been shown to also occur with
brevetoxin-B (PbTx-2 adduct miz 927) [78].

1.3.3.

AZA Chemistry

1.3.3.1. Structure and Analogue
The structure of the first AZA discovered, AZAl, was determined by one- and twodimensional NMR and high-resolution fast atom bombardment (FAB) MS and
MS/MS experiments were performed in positive and negative modes. The negatively
charged ion [M-H]' underwent charge-remote fragmentation with the sequential
cleavage of polyether rings, which provided spectra rich in structurally informative
ions [79]. However, the stereochemistry of AZAl initially proposed by Satake et al.
[79] was incorrect. The structure of AZAl (MW 841.5) was first reported in 1998
after successful isolation from Irish blue mussel (M edulis) material [80]. A cyclic
amine (or aza group), a unique tri-spiro-assembly and a carboxylic acid group gave
rise to the name AZA. The original structure reported in 1998 was found to contain
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errors after attempts of synthesis of AZAl [81-82]. The synthesised compound was
found to have a different chromatographic behaviour and discrepancies in its nuclear
magnetic resonance (NMR) spectrum compared to the compound isolated from
natural sources. Following the total synthesis by Nicolaou et al., the structure of
AZAl (and consequently the structures of other AZAs) has been revised. Figure 10
shows the revised structures of AZAs. A detailed review of the synthetic approach
and structure revision has recently been published [83].

Figure 10. (A) Originally proposed structure for AZAl [43], (B) revised structure
for AZAl [84].

Shortly after structure elucidation of AZAl, four additional analogues of the toxin
were discovered and, after their preparative isolation, their structure was determined
using MS and NMR techniques [85-86]. Three of these isolated analogues differ only
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in the number of methyl groups. Compared to AZAl, AZA3 is lacking the C22
positioned methyl moiety and AZA2 possesses an additional methyl at position Cg
(Figure 8). The other two analogues of the toxin (AZA4 and AZA5) proved to be
hydroxyl analogues of AZA3, showing the presence of an additional hydroxyl group
at either C3 (AZA4) or at C23 (AZA5), figure 11.

Figure 11. (A) Chromatogram showing the separation of the isomers, AZA4 &
AZA5, which was obtained using LC-MS3; AZA4 (3.73 min) andAZAS (4.63 min).
(B) and (C) are the mass spectra corresponding to AZA4 and AZA5, respectively
[87].

So far, only AZAs 1-5 have been preparatively isolated, with their structures verified
using NMR. Structural elucidation of other analogues has been solely based on the
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analysis of fragmentation patterns of the respective MS/MS spectra [88-90]. AZAs
produce characteristic product ion spectra, water loss [M+H]^^[M+H-H20]'^ for
quantitation with this transition been the most facile and A-ring loss [M+H]^^[M+HH20-Aring]^ for confirmation, this characteristic transition is used for distinguishing
between isomers AZAl and AZA6, (Table 3) [88-91].

Name

R*

AZAl
AZAl
AZAS
AZA4
AZAS
AZA6
AZAl
AZA8
AZA9
AZA 10
AZAll

H
CH3
H
H
H
CH3
H
H
CH3
CH3
CH3

R^
CH3
CHj
H
H
H
H
CH3
CH3
H
H
CH3

H
H
H
OH
H
H
OH
H
OH
H
OH

H
H
H
H
OH
H
H
OH
H
OH
H

[M+H]^

[M+H-HiO]^

842.5
856.5
828.5
844.5
844.5
842.5
858.5
858.5
858.5
858.5
872.5

824.5
838.5
810.5
826.5
826.5
824.5
840.5
840.5
840.5
840.5
854.5

(M+H-H20C,H,«02R'R^r
672.4
672.4
658.4
658.4
674.4
658.4
672.4
688.4
658.4
674.4
672.4

Table J. AZA structural assignments, R‘-R^ (see figure 8), and the molecule-related
and product ion masses using positive electrospray mass spectrometry.

Analysis of the different fragments has led to the identification of up to 27 different
naturally occurring analogues of AZAl as well as methyl esters of AZAs, which have
been identified to be storage artefacts (Table 4) [90]. These isomers have not been
properly characterized yet as it is first necessary to have purified material with
corresponding NMR spectra in order to prove stereo-chemical differences between the
compounds. Isolation of AZAl for production of a certified reference material (CRM)
using a different extraction procedure was reported recently [92]. Hepatopancreas
(HP) from M edulis were extracted with ethanol and partitioned with ethyl acetate
and IN NaCl solution as well as with hexane and 90% methanol. The sample was
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further purified using vacuum liquid chromatography on silica, size exclusion
chromatography (SEC) on Sephadex LH-20, flash chromatography on LiChroPrep
RP-8, and a final purification step on a Cg- silica column. Using a HPLC reverse
phase material in the final purification step has increased purity to > 95 % as
determined by NMR and LC-MS [93].

Abbrev.

Original
analogues

Substituent

Name

Ref.

AZAl

Azaspiracid 1

AZA2

8-methyl-azaspiracid

14

AZA3

22-desmethvi-azaspiracid

14

AZA4

AZA3

OH

22-desmethyl-3-hydroxy-azaspiracid

13

AZA5

AZA3

OH

22-desmethyl-23-hydroxy-azaspiracid

13

AZA6

22-desmethyl-8-meth\i-azaspiracid

1 5, 16

AZA7

AZAl

OH

3-hydroxy-azaspiracid

16

AZA8

AZAl

OH

23-hydroxy-azaspiracid

16

AZA9

AZA6

OH

22-desmethyl-3-hydroxy-8-melhyi-aza

16

AZAIO

AZA6

OH

22-desmethyl-23-hydroxy-8-methyl-aza

16

AZA I 1

AZA2

OH

3-hydroxy-8-methyl-azaspiracid

16

AZAl 2

AZA2

OH

23-hydroxy-8-methyi-azaspiracid

16, 17

AZA 13

AZA 3

2 OH

22-desmethyl-3.23-dihydroxy-azaspiracid

17

AZAM

AZAl

2 OH

3,23-dihydroxy-azaspiracid

17

AZA 15

AZA6

2 OH

22-desmethyl-3,23-dihydroxy-8-methyl-aza 17

AZAM

AZA2

2 OH

3,23-dihydroxy-8-methyl-azaspiracid

AZA 17

AZA3

COOH

carboxy-22-desmelhyi-azaspiracid

AZA 18

AZAl

coon

carboxy-azaspi rac id

AZAM

AZA6

COOH

carboxy-22-desmelhyi-8-methyl-azaspiracid 17

AZA20

AZA2

COOH

carboxy-8-methyl-azaspiracid

AZA21

AZA3

COOH

+ OH carboxy-22-desmethyl-3-hydroxy-aza 17

AZA22

AZAl

COOH

+ OH carboxy-3-hydroxy-azaspiracid

AZA23

AZA6

COOH

+ OH carboxy-22-desmethyl-3-hydroxy-8

methyl-azaspiracid

17
15, 17
17

17

17

17

AZA24

AZA2

COOH

+ OH carboxy-3-hydroxy-8-methyl-aza

17

AZA25

AZA3

-H20

21 -22-dehydro-22-desmethyl-azaspiracid

17

AZA26

AZAl

-H20

21-22-dehydro-azaspiracid 17

AZA27

AZA6

-H20

21 -22-dehydro-22-desmethyl-8-methyl-aza 17

AZA28

AZA2

-H20

21-22-dehydro-8-methyl-azaspiracid

17
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AZA29

AZA3

COOCH3

22-desmethyl-azaspiracid-1 -methyl-ester

17

AZA30

AZAl

COOCH3

Azaspiracid-1-methyl-ester

17

AZA31

AZA6

COOCH3

22-desmethyl-8-methy l-aza-1 -methyl-ester

17

AZA32

AZA2

COOCH3

8-methyl-azaspiracid-1 -methyl-ester

17

Table 4. Overview of all reported AZA analogues

1.3.3.2.

AZA Charge Remote Fragmentation

The collision-induced dissociation (CID) mass spectra of marine toxins containing
fused polyether rings often display signals due to multiple water losses from the
precursor ion that are usually regarded as non-informative for structural elucidation
[94-96]. In positive electrospray ionization (ESI), AZAs can lose up to five water
molecules during multiple tandem MS experiments. When using triple-stage
quadrupole (QqQ) instruments for the analysis of AZAs, the QqQ can produce
fragments in the collision cell that may not be first-generation ions. The relatively
lower energy characteristic of the resonance activation used for CID in ion-trap MS
experiments allows the protonated molecule and product ions to be sequentially
segmented. In an ion-trap instrument, using relative collision energy (RCE) values
less than 40%, water loss fragments tend to dominate the second-order and, in the
case of AZAs, also the third-order spectra.

The use of higher RCE values greater than 40%, resulted in extensive fragmentation
of the selected precursor ion, [M+H]^, was observed. Collision induced dissociationmass spectrometry (CID-MS) of AZAl, AZA2 and AZA3, in positive ion mode,
displayed product ions containing nitrogen which were produced from water losses
and charge-remote fragmentation of the backbone starting at Cg on the A-ring down to
C27-C28 at the F/G rings. From studies carried out using deuterated AZAl [91], the
results found, showed that the first water loss was 20 Da, which was due to D2O, this
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demonstrates that the diol moiety at

C20-C21

is the location for this process. A retro-

Diels-Alder reaction was the next stage in fragmentation which involved the A-ring
and thus is a very important process for the discrimination of AZAs (Figure 12). As a
result of this retro-Diels-Alder reaction subsequent fragmentation occurred at the Cring,

C19-C20,

E-ring and

C27-C28

(Figure 13) this reaction contains the identification

of the major product ions and processes. The reason for conducting the above studies
was to assign an isomer of AZAl, named AZA6, as 8-methyl-22- demethyl AZA
(Figure 8, R’ = CH3;

= H) [97]. Both AZAl and AZA6 have a molecule-

related ion, [M+H]^, at m/z 842 and the water-loss ion [M+H-H20]\ at m/z 824.

R'

Figure 12. The first two stages of the CID fragmentation of AZAs and the
mechanism of A-ring cleavage.
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Figure 13. The MS^ spectrum of AZAl produced using QIT MS. The sequential
fragmentation of AZAl produces product ions by processes shown by the
annotation.

It is the A-ring fragmentation in the above mass spectra that results in the difference
observed between these two ions. The observation was that AZAl displayed an ion at
m/z 672 and for AZA6 the corresponding ion was seen at m/z 658 (Table 3) The
formation of the AZA6 product ion was found to be 14 amu smaller than the
corresponding ion of AZAl, and all remaining spectral data gathered for AZA3 and
AZA6 were virtually identical, indicating a similar C10-C46 region. AZA4 and AZA5
of which are two AZAs in mussels with low abundance were were identified as the 3and 23-hydroxy analogues of AZA3, respectively [60]. Studies were conducted on
Protoperidinium spp, and these two toxins were found not to be present [89] thus it is
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probable to assume that they are produced as a result of bioconversion in shellfish.
The structures of the other AZAs are proposed on the basis of multiple tandem MS
data and by analogy to the confirmed toxin structures.

1.4.

Mass Spectrometric Methods for AZAs

The unambiguous identification of AZA toxins in marine samples need mass
spectrometric methods, such as tandem MS techniques, to develop confirmatory
assays that will allow identification of AZA [98]. The technique of multiple tandem
MS which offers unrivalled selectivity is well suited for the determination of AZAlAZA3 and the minor AZA analogues in shellfish. This technique offers the best
means for the determination of trace contaminants in complex matrices [99-101].

Draisci et al. [101] developed a liquid chromatography multiple tandem-mass
spectrometry (LC-MS/MS) method for the analysis of AZAl using a triple
quadrupole (OqQ) instrument. However, the multiple reaction monitoring (MRM)
transitions used in this methodology are not structure-diagnostic, as they are based on
successive water losses [M+H-nH20]^ from the molecular ion [M+H]^. Thus, this
kind of methodology requires full chromatographic resolution of the isobaric AZA
isomers. Conversely, LC-MS/MS has been used to produce CID spectra of the
predominant AZAs using QqQ and ion-trap (QIT) instruments to study the
dissociation behaviour of these compounds and propose a variety of structurediagnostic ions susceptible of being chosen for MRM transitions [102], [98]. LC-MS^
methods developed using a QIT MS have been shown to be particularly effective for
the rapid determination of the AZAs.
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The fragmentation of the A-ring in the structure of AZAs (Figure 12) allows the
selection of unique precursor/product ions ([M+H]^ —^ [M+H-H20]^

[M+H-H2O-

Aring]^) for the eleven known AZAs, thus eliminating the requirement for complete
chromatographic separation [97], [87], [89].

In terms of instrumentation for the investigation of new AZA analogues, a
requirement of high sensitivity MS methods are needed to establish AZAs detection.
By using a QIT MS, the analyst will be provided with MSn data which reveals the
sequential processes of mass fragmentation. A compliment to this approach is the use
of a system that offers the analyst not one, but two analysers, and these analysers do
not necessarily have to be of the same type (hybrid). A hybrid quadrupole time-oftlight (QqTOF) MS will provide the much needed high mass accuracy data for
analytes and their product ions which are produced by CID. This as a result
complements the QIT MS data by confirmation of the proposed formulae.

Alternatively, triple QqQ can operate in a mode referred to as pseudo-MS^,
characterised by two stages of CID. To perform pseudo-MS^ experiments on a QqQ
MS equipped with an ESI interface, in-source CID of the pseudo molecular ion is
performed by increasing the declustering potential (DP) in the skimmer region.
Fragment ions are then introduced into the collision cell in the vacuum region of the
MS for further CID. Finally, the secondary fragment ions pass through the final mass
filter at a pre-selected mass. This approach has been employed in the analysis of
peptide mixtures [103] and lipid extracts of cellular origin [104]. Pseudo- MS^ has
also aided in the sequencing of biopolymers [105]. Thus, pseudo-MS^ experiments
represent analytically useful extensions of the standard MS^ capabilities of a QqQ.
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The QqQ offers both selected ion monitoring (SIM) and MRM. AZAs do not form
sodium or ammonium adducts that are often observed in electrospray experiments.
This result means that SIM methods can only use one ion for identification. However,
the optimisation of the [M+H-H20]^ production in the ion source allows the
implementation of an SIM methodology for AZAs based upon two ions rather than
one. Conversely, SIM methodologies generally suffer from interferences due to
isobaric components and are therefore much less selective than tandem MS
methodologies.

Subsequent to the in-source fragmentation studies that were performed, tandem mass
spectrometric methodologies were undertaken and the developiuent of MRM
experiments have been previously carried out using three transitions: [M+H]V[M+HH20]\

[M+H]V[M+H-H20-C9Hio02R'rY

and

[M+H-H20]/[M+H-H20-

C9Hio02R'R^]^ for AZA1-AZA6. By use of MRM it was found that the signal is
smoother in this operation mode than in SIM, due to the higher selectivity. Even
though there may be huge difference in terms of intensity for each MRM transition,
the limit of detection (LOD) and limit of quantitation (LOQ) are very similar for the
three of them. The reason for this is that the selectivity of the [M+H]^/[M+H-H20Aring]^ and [M+H-H20]T[M+H-H20-Aring]^ transitions is better, which leads as
well to an improved signal to noise ratio.

For my research into AZA biotransformation pathways, a QqQ with multiple reaction
monitoring was employed as a screening for their initial confirmation (A-ring) and
quantitation based on two transitions that have previously been developed. These
included [M+H]^ —> [M+H - H20]^ transition (quantitation) and [M+H]^

[M+H -
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H20-A-ring]^ (confirmation) for AZAl-12. To compliment this technique the use of
orbitrap technologhy (LTQ Orbitrap XL) was employed (see section 1B introduction).
The most powerful attributes of this instrument is that the orbitrap mass analyser
offers high mass accuracy and high mass resolution, with its extreme dynamic range
and overall versatility the intermediates of AZAl and AZA2 were both identified
(AZA17 and AZAl9). These two transitions were added to the existing MRM method
on the QqQ and the collision energy’s optimised for best response. These are as
follows; [M+H]^

[M+H - H20-C02]^ for quantitation at collision energy (54 V)

and [M+H]^ ^ [M+H - H20-C02-A-ring]^ transition for confirmation at collision
energy (80 V). It is fair to say that without orbitrap teehnology and use of Pulsed Q
Collision

Induced

Dissociation (PQD) (see section

IB

introduction) these

intermediates would not have been identified and with such low error part per million
(PPM) (see chapter 111, IV).

1.4. L

Meih ods of Detection for AZA s

Mass spectrometric methods for AZAs are urgently needed to allow confirmatory
assays that allow unambiguous identification of AZAs in marine samples [98]. LCMS has been used for the determination of AZA1-AZA3. Conversely, LC-MS/MS
offers the best means for the determination of trace contaminants in complex
matrices, including shellfish [106-100]. Multiple tandem MS methods for AZAs have
been developed using QqQ instruments [101,108] and ion-trap instruments
[97,87,107,89]. Refer to appendices chapter 35,

“Azaspiracids: Chemistery,

Bioconversion and determination ” and chapter 13, “Phycotoxins

34

1.4.2.

Mouse Bioassay (MBA) versus LC-MS and LC-MS^'

AZP monitoring programmes initially relied exelusively on non-selective mouse or rat
bioassays, whieh had been developed to monitor DSP toxicity in shellfish [109-110].
However, a combination of the poor sensitivity of these methods for detecting AZAs,
coupled with the testing of only the digestive glands of shellfish, led to several
incidents of acute human intoxications. It has been demonstrated that unlike DSP
toxins [111], AZAs can migrate from the digestive glands to other shellfish tissues
[68, 112-113], leading to false-negative assays.

This hypothesis has been criticised by Hess et al. [114], who believe that the
distribution of a toxin across different tissues is difficult to study due to cross
contamination between organs during either sample pre-treatment or dissection stage.
However, it is believed that cross-contamination is not responsible for values as high
as the ones showed by James et al. [112], where in some samples, the HP contained
only 4% of the total AZAs present in the mussel. In contrast, the poor reproducibility
of the MBA, coupled with false-positives from free fatty acids in the extracts [115],
have diminished confidence in this testing approach. Mass spectrometric methods for
AZAs are urgently needed to allow confirmatory assays that allow unambiguous
quantatation of AZAs in marine samples [98].

A recent review published by the European Food Safety Authority (EFSA) [61] on
marine biotoxins in shellfish clearly states that the MBA for lipophilic biotoxins has
“shortcomings” and is not considered an appropriate tool for control purposes because
of the high variability in results, the insufficient detection capability and the limited
specificity. The MBA (Table 5) is not capable of detecting concentrations
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considerably below the current EU levels (0.16 |ig/g). Thus, effects of commercial
processing on lipophilic biotoxins cannot be monitored using the MBA. This finding
undermines the results presented by Hess et al, [116] on the performance of MBA in
relation to lipophilic toxins for the detection of AZAs in naturally contaminated
mussel (M Edulis) HP tissue homogenates.

Hess et al performed a study on the HP and stated that the probability of a positive
mouse bioassay to perform well at the current regulatory limit of 160 pg/kg was
found to be ca. 95%. Hess et al also stated that it therefore appeared that the mouse
bioassay performed very well in the implementation of this limit and that the study
carried out very strongly suggested that the MBA and LC-MS/MS techniques could
be considered equivalent in the implementation of the current regulatory limit set for
AZA in shellfish.

The MBA is not capable of detecting concentrations of OA, AZA and PTX toxins
below their current EU regulatory limit values according to the EFSA finding. Since
limit values for marine biotoxins in shellfish meat are meant to protect the consumer,
the effect of processing should be considered when testing shellfish in official control.
For lipophilic biotoxins the multitoxin-methods based on LC-MS/MS are specific,
have sufficient limits of detection and therefore the greatest potential to replace the
mammalian bioassays.
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Toxin group

Mouse
bioassay

AZA

Rat bioassay

AZA

Ability to
perform at
the current
EU limit
95% probality
to detect at he
limit of 160 pg
AZAl eq./kg
Not
established

Specificity

Interlaboratory
validated/
standardised

None (any
lipophilic
biotoxin or
bioactive
compound)
Limited (any
lipophilic
biotoxin with
diarrhoeic
effect
following oral
exposure)

No

No

EC: European union, AZA: azaspiracid, eq: equivalents.
Table 5. Performance of official bioassays for the determination of lipophilic
marine biotoxins in shellfish as mentioned in EU Regulation (EC) No 2074/2005,
161]

LC-MS has been used for the determination of AZA1-AZA3 [65]. In this method, a
solid phase extraction (SPE) step with DIOL stationary phase has to be employed in
order to remove interferences that may obscure the analyte signals. However, the need
of a clean-up step makes this methodology unsuitable for monitoring, as it is too slow.
Conversely, LC-MS/MS offers the best means for the determination of trace
contaminants in complex matrices, including shellfish [106], [100]. The full
resolution of eleven AZAs using reversed-phase chromatography has been achieved
[89], [117], and the possibility of determining AZAl-AZA 10 without complete
chromatographic separation has been demonstrated by exploiting the ability of LCMS

to resolve isomers using prescribed mass selection [87], [117]. Refer to

appendices on different LC-MS" approaches for the analysis of AZAs, chapter 13
“Phycotoxins
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1.5.

Toxicology of AZAs

1.5.1.

Relative Potency ofA nalogues

Further toxicological data are needed for the establishment of robust Toxicity
equivalency factor (TEF) for the oral route of administration for all toxin groups. The
assumption of dose additivity should be assessed, according to the European food
safety authority following exposure to combinations of toxin analogues and milligram
amounts of purified toxins should be produced for this purpose. The TEF values
should be revised when studies on acute oral toxicity data for the relevant analogues
of each toxin group become available. The following table 6 represents AZAl-3 and
there toxicity equivalency factors.

Toxin Group

Analouge
AZAl

TEF
1

AZA -group toxins
(AZA-equivalents)

AZA2

1.8

AZA3

1.4

TEF: Toxicity equivalency factors.
Table 6. TEFs for regulated marine biotoxins [25J.

1.5.2. Human Toxicity
Unlike many of the other well-described marine phycotoxins, relatively little is known
about AZA. Similar to DSP toxins, human consumption of AZA-contaminated
shellfish can result in severe acute symptoms that include nausea, vomiting, diarrhea,
and stomach cramps. Due to the limited data available from many of the AZP events,
nearly all information regarding AZA toxicology has been obtained from controlled in
vitro and in vivo experiments. Many of these efforts have been directed towards
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assessing the risk of AZA consumption in contaminated shellfish and in turn,
identifying the molecular target(s) of AZA, which is currently unknown,

1.5.3. Human Health Issues
All symptoms observed in humans following consumption of shellfish contaminated
with AZAs appear within hours of ingestion, and as previously mentioned include
nausea, vomiting, severe diarrhea and stomach cramps [112], The illness persists for
2-3 days and full recovery has been established in all cases during the incident in
Arranmore Island, 1997 [59], To date, no long term effects or illness have been
reported. AZP remains a rare illness, as only 5 intoxication events have been reported
to date (Table 1). Due to the similarity with ‘food poisoning' or DSP, it has to be
assumed that more cases exist; however, it is likely that there is a high percentage of
under-reporting due to the symptoms of the illness disappearing rapidly (i.e., days)
and no precedence for fatality.

1.5.4. Risk of Chronic Effects
Given that shellfish production sites remain open for production if AZA
contamination levels are below the EU regulatory limit (160 pg/kg shellfish meat), a
large number of shellfish consignments with low levels of AZAs have been produced
in Ireland since 2001, and subsequently marketed and consumed in Europe. Some
chronic illnesses are caused by chemicals that are retained in the human body for a
long time. A prime example for such a chronic condition is cancer, which may be
caused through the accumulation of carcinogens that may be absorbed with fatty
foods, transferred to the human body through the blood stream and accumulate in all
fatty tissues of the body. Therefore, by analogy, in order to evaluate whether AZAs
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have a potential for causing chronic effects, it is important to know whether AZAs, or
their metabolic products, are distributed to the body via the blood stream, or whether
they are simply excreted with food after exerting their toxic action in the intestine.
Although pilot studies with mice have shown increased occurrence of cancer and
hyperplasia with a protracted rate of recovery in the test animals exposed to AZAl
[102], this increase in cancer was not observed in a dose-dependent manner (1 case at
highest dose of 50 pg/kg body weight, 3 cases at the intermediate dose of 20 pg/kg
body weight). Also, the number of mice used in this study was relatively low (due to
a lack of toxin) and the results may only be considered indicative, suggesting the need
for further studies to elucidate the carcinogenic potential of AZAs. In addition, other
toxic effects were observed in mice exposed to AZA over 20 weeks [102], particularly
in the highest exposure dose, therefore, chronic effects cannot be excluded at this
stage.

Damage caused by AZA to epithelial cells of the intestinal tract in vivo [100, 108],
were supported in vitro by Hess et al. [118], providing a model to explain the
diarrhetic symptoms in humans. It is conceivable that AZAs may contribute to
chronic disorders in the golgi intestinal tract, such as irritable bowl disorder (i.e.,
Crohn’s disease, ulcerative colitis), or cancers of the stomach, intestines and colon.
However, it remains to be established whether the suspected bioavailability and
toxicity of AZAs are similar when dosed as part of naturally contaminated shellfish as
food.

To date, due to the scarcity of epidemiological data, it has not been possible to
establish any link between AZAs and the occurrence of cancer or birth defects in
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humans. Any studies presuming consumption of AZA-contaminated shellfish and
statistically comparing a hypothetically increased occurrence of chronic disease with
levels of AZA in shellfish would be convoluted by the multitude of potential
carcinogenic agents and contaminants of any consumer area. Therefore, research in
this area should focus on the toxicokinetics (i.e., absorption, metabolism, distribution,
and elimination) of AZAs in animals to establish the possible fate of AZAs in the
human body, until larger amounts of synthesized AZA or AZA contaminated shellfish
are available facilitating statistically valid long-term exposure trials. Also, when the
mode of action is clarified from in vitro studies, further studies may be necessary to
evaluate chronic effects, depending on the mechanism elucidated.

1.5.5. Safe Levels ofAZAs in Shellfish and Allowable Daily Intake
Considering the lack of knowledge on the long term exposure potential of AZAs with
the fact that all other shellfish toxins have only been evaluated for their acute toxic
potential, experts consulted during the ad hoc consultation by FAO/IOC/WHO [119]
advised regulators to consider only known acute effects in humans when establishing
safe levels of AZAs in shellfish. Allowable daily Intakes require the evaluation of
repeated intake and a risk from long term exposure. As long term effects have not
been shown to date in humans, the establishment of allowable daily intakes is not
appropriate. Therefore, a proposed regulatory level of AZAs in shellfish has only been
obtained through estimation of the consumption of a single portion of shellfish and
through the estimation of an Acute Reference Dose (ARfD). Analogous to other
formal risk assessments, the risk assessment by Food Safety Authority Ireland (FSAI)
also used epidemiology data to establish the ARfD 3.
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This risk assessment was based on a statistical approach, which makes use of known
distributions of all components involved in a poisoning event (i.e., mussel weight,
portion size consumed, concentration of AZAs in mussels, etc.), and the result is a
distribution of most likely ARfDs. It is then the responsibility of risk managers and
regulators to adapt an ARfD from this distribution (e.g., the most probable value or
the ARfD covering with 95% probability all possible ARfDs). The selected ARfD is
then used, in combination with an appropriate safety factor, to derive a no observable
adverse effect level (NOAEL). This statistical approach used for risk assessment of
AZAs is novel and has not been used by the FAO/IOC/WHO expert group; however,
as cited in the risk evaluation by FSAl, “/7 is the opinion of expert toxicologists that a
more accurate estimate may he obtained using this method' [120].

The FSAl 2006 risk assessment was the second risk assessment by this group,
following the first one in 2001 [121]. The reason for review of the earlier risk
assessment was the availability of new scientific data allowing a re-estimation of the
amount of toxin consumed by the people who fell ill during the 1997 Arranmore AZP
incident (Table 1), which is still the best documented incident to date. The new
evidence mostly related to new information on the tissue distribution of AZAs in
mussels (M edulis), the effects of heat-treating mussels on their toxin content and the
ratios of AZA analogues observed in shellfish tissues [114]. The median, or most
likely ARfD derived in this assessment was 0.63 pg/kg body weight, while the most
likely lowest observable adverse effect level (FOAEF) was divided by a safety factor
of 3. When assuming consumption of a 250 g portion of shellfish flesh and a human
average weight of 60 kg, this ARfD translates into a proposed regulatory level of
AZAs in shellfish flesh equal to 160 pg/kg.
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Co-incidentally, this is the same level as was transposed into EU legislation in 2004
(853/2004/EC) [122]. This limit of 160 pg AZA/kg shellfish in flesh has also been
proposed by the EU Commission for Health and Consumer Protection (EU-DG
Sanco) to Codex Alimentarius as part of a draft Codex standard on fish and fisheries
products during recent meetings of Codex [123,124] As this limit had also been
implemented in EU legislation since 2002 (2002/225/EC) [119], although now
superseded by 853/2004/EC [122], it had been implemented in Ireland since 2002.
Surveillance information from the Marine Institute, the Irish National Reference
Laboratory (NRL) as cited in Anon. (2006) [59], suggests that numerous lots of
shellfish have been produced since 2002 that were contaminated at levels close to this
concentration.

Although there is a high likelihood of under-reporting of illnesses due to the rapid
recovery, it has been estimated by the authors that millions of portions of shellfish
(several thousand tons) with low but significant AZA-levels have been consumed
since 2001 (contamination range of 100 - 160 pg/kg). Therefore, assuming a
reporting rate of only 0.1 %, there should have been thousands of reports of illness if
the current limit of 160 pg/kg was unsafe.

However, not a single report was received on any poisoning incident from these
shellfish, over the period from 2001 to 2007. Therefore, it can be assumed that
existing risk management practise has shown in retrospect that this level is indeed a
safe level protecting consumers from acute effects of AZAs in shellfish. It should be
noted that this limit has been derived from epidemiological observations caused by a
mixture of naturally occurring analogues.
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CHAPTER IB

Instrumentation
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1.

Liquid Chromatography Mass Spectrometry (LC-MS)

LC-MS, is a technique that combines the physical separation capabilities of liquid
chromatography with the mass analysis capabilities of mass spectrometry. LC-MS is a
powerful technique used for many applications which have very high sensitivity and
specificity. Generally, its application is oriented towards the specific detection and
potential identification of chemicals in the presence of other chemicals (in a complex
mixture).

A major difference between traditional high performance liquid chromatography
(HPLC) and the chromatography used in LC-MS is that in the latter case the scale is
usually much smaller, both with respect to the internal diameter of the column and
even more so with respect to flow rate since it scales as the square of the diameter.
For a long time, 1 mm columns were typical for LC-MS work (as opposed to 4.6 mm
for HPLC). More recently, 300 pm and even 75 pm capillary columns have become
more prevalent. At the low end of these column diameters the flow rates approach 100
nL/min and are generally used with nanospray sources.

The coupling of LC and MS allows for two major incompatibilities and these include
as follows; LC uses liquid as a mobile phase, often containing a significant proportion
of water, which is pumped through the column at a flow rate of typically 1 ml min'’
and at atmospheric pressure, while MS operates in the gas phase and at a pressure of
around 10'^ torr. Therefore, it is not possible to pump the eluate from the LC column
directly into the source of a mass spectrometer. Analytes that are likely to be
separated by LC for the majority are relatively non volatile or thermally labile, like
marine biotoxins therefore few of them are volatile enough for direct analysis by gas
chromatography (GC). It is possible to perform some degree of chemical
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derivatisation to increase volatility for GC such as with the marine toxin domoic acid
[126], most toxins are too thermally labile and chemieally unstable to be analysed by
GC. As a result of these ineompatibilities one must consider the use of an ionisation
interface.

2.

Sample Introduction

The method of sample introduction to the ionisation source often depends on the
ionisation method being used, as well as the type and complexity of the sample. The
sample ean be inserted directly into the ionisation souree, or can undergo some type
of chromatography en route to the ionisation source. This latter method of sample
introduction usually involves the mass speetrometer being coupled directly to a
HPLC, GC or capillary electrophoresis (CE) separation column, and hence the sample
is separated into a series of components which then enter the mass spectrometer
sequentially for individual analysis.

3.

Interface and Methods of Sample Ionisation

The primary purpose of an interface is to ensure that the operational requirements for
each of the techniques are not comprised by the other. A critical requirement in LCMS is the generation of ions [127]. Therefore an interface for an LC-MS system must
be able to evaporate the mobile phase and ionise the analyte. There are many
ionisation methods available and eaeh has its own advantages and disadvantages. The
ionisation method to be used should depend on the type of sample under investigation
and the mass spectrometer available. ESI was the method of sample ionisation used
for the analysis of AZA toxin. Below is a list of the different methods of ionisation
with emphasis on ESI.
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Ionisation methods include the following:

Atmospheric Pressure Chemical Ionisation (APCI)
Chemical Ionisation (Cl)
Electron Impact (El)
Electrospray Ionisation (ESI)
Fast Atom Bombardment (FAB)
Field Desorption / Field Ionisation (FD/FI)
Matrix Assisted Laser Desorption Ionisation (MALDI)
Thermospray Ionisation (TSP)

3.1.

Electrospray Ionisation (ESI)

ESI is one of the Atmospheric Pressure Ionisation (API) techniques and is well-suited
to the analysis of polar molecules ranging from less than 100 Da to more than
1,000,000 Da in molecular mass. ESI refers to process by which ions are produced in
the source of the instrument and is the most widely used means of generating ions
[127] as it offers high ionisation efficency for ions which protonate or deprotonate
readily. However, for compounds that are neutral or difficult to ionise APCI is better.

Several different types of mass analysers are used in ESI tandem MS (or ESI-MSMS) which is the standard acronym for electrospray ionisation tandem mass
spectrometry, the better known of which include quadrupoles , time-of-flight (TOF)
analysers, magnetic sectors , and both Fourier transform and QIT. The compatibility
of different analysers with different ionisation methods varies. For example, all of the
analysers listed above can be used in conjunction with ESI, whereas MALDI is not
usually coupled to a quadrupole analyser. The use of tandem mass spectrometry refers
to mass analysers that are able to perform two-stage (or multistage) mass analysis of
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ions and so can therefore be used for structural and sequencing studies. Two, three
and four analysers have all been incorporated into commercially available tandem
instruments, and the analysers do not necessarily have to be of the same type, in
which case the instrument is a hybrid one. More popular tandem mass spectrometers
include those of the quadrupole-quadrupole, magnetic sector-quadrupole, quadrupoletime-of-flight, and the more recently linear ion trap/orbitrap mass spectrometer. These
mass analysers have different features, including the m/z range that can be covered,
the mass accuracy, and the achievable resolution. Figure 14 represents a standard ESI
source.

sampling conc/oritice
skimmer

counter electrode
drying gas
solute

\ \

analyser
(10-4/10-6 mbarj

nehulising gas

atmospheric pressure

* Imbar*

Figure 14. Standard electrospray ionisation source. Reproduced from lecture
power point presentation.
During standard ESI [128] (Figure 15) the sample is dissolved in a polar, volatile
solvent and pumped through a narrow, stainless steel capillary (75 - 150 micrometers
i.d.) at a flow rate of between 1 pL/min and 1 mL/min. A high voltage of 3 or 4 kV is
applied to the tip of the capillary, which is situated within the ionisation source of the
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mass spectrometer, and as a consequence of this strong electric field, the sample
emerging from the tip is dispersed into an aerosol of highly charged droplets, a
process that is aided by a co-axially introduced nebulising gas flowing around the
outside of the capillary.

This gas, usually nitrogen, helps to direct the spray emerging from the capillary tip
towards the mass spectrometer. The charged droplets diminish in size by solvent
evaporation, assisted by a warm flow of nitrogen known as the diydng gas which
passes across the front of the ionisation source. Eventually charged sample ions, free
from solvent, are released from the droplets, some of which pass through a sampling
cone or orifice into an intermediate vacuum region, and from there through a small
aperture into the analyser of the mass spectrometer, which is held under high vacuum.
The lens voltages are optimised individually for each sample.

capillary, 3 4 kV

druplet
evapuraling

0

cuntaining
ions

\

>

ions evapuraling
from the surface of
the droplets

Figure 15. The ESI process as reproduced from lecture power point presentation
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4.

Mass Spectrometers (MS)

The main advantage of linking LC with MS are that liquid chromatograpy provides
separation of the analytes, which in many cases are part of a complex matrix.
Identification is based on the comparison of the retention times of the unknowns with
those of reference material determined under the same experimental conditions. Their
are so many compounds, that even having the same retention time as the reference
material, one cannot say with absolute certainty that the two compounds are the same.
However mass spectra of many compounds are specific enough to allow their
identification with a high degree of confidence, if not complete certainty.

4.1.

How MS Instruments Work

Mass spectrometers have three essential parts. The first is the source, which produces
ions from the sample. The second is the mass analyser, which resolves ions based on
their mass/charge {m/z) ratio. The third part is the detector which detects the ions
resolved by the mass analyser. In short, the mass spectrometer converts components
of a mixture to ions and then analyses them on the basis of their m/z. The data are
automatically recorded by the data system and can then be retrieved for manual or
computer-assisted interpretation. Of course, there is more to the functioning MS
system. They are controlled by sophisticated computers and software and the data the
instruments generate are handled by similarly sophisticated computer data systems.
The instruments are also equipped with vacumn-pump systems to maintain the mass
analysers, detectors and sometimes the ionisation source at high vacuum to give the
ions a reasonable chance of travelling from one end of the instrument to the other
without any hindrance from air molecules.
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4.2.

What Do We Want From MS Data

There are three things that we want from our MS data, the first is sensitivity.
Instruments are needed that are routinely capable of obtaining data on femtomole (10*
moles) or less. Second, we need resolution, which is the measure of how well we
can distinguish ions of very similar m/z values. The MS instruments that deliver the
highest resolution (magnetic sector, fourier transform and orbitrap instrumentation)
can reliably distinguish between ions that differ in m/z by as little as 0.001 atomic
mass units (amu). Finally, we need mass accuracy; this means that the measured
values for both ions and their fragment ions must be as close as possible to their real
values.

5.

Single and Triple Stage Quadrupole (QqQ) Mass Analysers

5.1.

Single Quadrupole MS

The quadrupole is the most widely used analyser due to its ease of use, mass range
covered, good linearity for quantitative work, resolution and quality of mass spectra.
The quadruple mass analyser consists of four metal rods arranged in parallel. Direct
current (dc) and radiofequency (rf) voltages applied to the rods create a magnetic field
that causes ions to follow a corkscrew trajectory as they proceed down the axis
between the rods. Depending on the voltage applied to the rods, ions of a specific m/z
value will pass through the quadrupole, whereas ions of greater or lesser m/z values
will fly outwards and faill to pass through the quadrupole. By sweeping the
radiofrequency voltages on the rods, ions of increasing m/z values can be analysed.
(Figure 16).
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From
ion source

Figure 16. Single quadrupole diagram. Reproducedfrom Applied Biosystems.
The positive pair of rods is acting as a high mass filter, the other pair is acting as a
low mass filter. The resolution depends on the dc value in relationship to the rf value,
and the quadrupoles are operated at constant resolution (constant rf/dc). For a selected
amplitude of the dc and rf voltages, only the ions of a certain m/z ratio will resonate,
have a stable trajectory to pass the quadrupole and be detected. Other ions will be de
stabilised and hit the rods. The performance (i.e. ability to separate two adjacent
masses across the applicable range) depends on the quadrupole geometry, on the
electronics, on the voltage settings and the quality of the manufacturing. Increasing
the resolution means that fewer ions will reach the detector, affecting the sensitivity;
that is why quadrupoles are low-resolution instruments. If the continuous voltage dc is
switched off, we have a transfer only device like the hexapoles or octopoles used to
transfer and focus the ions into the mass spectrometer optics.

The quadrupole can be used in two acquisition modes: SIM, also called single ion
recording (SIR), and scan mode. In the scan mode, complete spectra are repeatedly
measured between two extreme masses; the dc and rf voltages are ramped while
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keeping a constant rf/dc value. The sensitivity is a function of the scanned mass range,
scan speed and resolution. To increase the sensitivity, either the range of masses
scanned is decreased or the scan time is increased. In the former case, analytical
information may be lost, and in the latter case, a good mass spectrum may not be
obtained. If the analysis aims at detecting target compounds of known spectral
characteristics with high sensitivity, SIM is used. In this mode, the amplitude of dc
and rf voltages are set to observe one or more specific m/z values, providing the
highest sensitivity in single quadrupole mass spectrometers, since more time can be
spent on acquisition of data for each selected value. That time can be adjusted; it is
called the dwell time.

When using a single quadrupole instrument, it is possible to obtain fragmentation by
using a technique called in-source CID, allowing a study of spectral fragments and
consequently providing structural information. The fragmentation takes place before
the introduction of the ions into the optics of the mass spectrometer. This technique is
useful if there is no chromatographic interference.

5.2.

QqQMS

The triple quad is composed of two of these quadrupoles (Q1 and Q3). These are
separated by a somewhat different quadrupole (q2; the lower case designation is
widely accepted convention), which is governed by radiofrequency voltages only. The
middle quadrupole q2 serves as a collision cell, in which collisions between ions and
neutral gas atoms lead to ion fragmentation. The detector is placed after Q3. The triple
quadrupole operates in two general ways. In the first, ions from the source are
analysed by rapid scanning of Ql, such that m/z values of all ions coming from the
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source ay any given moment are recorded. This is referred to as “full scan” analysis
and yields signals for all the ions (e.g., singly, doudly, triply charged, etc.) coming
from the source. This can be considered a “snapshot” of the ions entering the source
over the time interval of the scan (typically about 1 s).

The other way in which the triple quad is operated is to use Q1 as a mass filter, in
which the voltage settings are fixed to allow ions of a specific m/z value to pass
through. Those ions then enter q2, where they collide with argon gas (Ar) atoms and
undergoe fragmentation referred to as CID. The fragment ions thus produced are
analysed on the basis of their m/z by Q3, which scans repeatedly over a designated
mass range to detect the fragment ions. This latter mode of operation is how the triple
quad acquires tandem MS data. The efficiency of MS-MS analysis by a triple quad
depends on the properties of the ions being analysed and on the instrument settings,
including the pressure of the Ar gas in q2 and the energy settings used for CID. In
most MS-MS on triple quads, only a fraction of the precursor ions that enter q2
actually undergoe fragmentation.

Moreover, the fragmentation that does occur is sometimes more extensive that in an
ion trap (see below). Thus, optimal MS-MS performance of a triple quad requires
careful adjustment of instrument parameters in order to obtain the optimum degree of
ion fragmentation. The accuracy of quadrupole mass analysers allows selection of
specific peptide ions (by Ql) and analysis of fragment ions from MS-MS (by Q3) to
within at least ±0.5 amu of their true m/z values. It is also possible to perform pseudoMS^ experiments by in-source CID, where fragmentation takes place before the
introduction of the ions in the vacuum region.
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The great advantage of the triple quadrupole instrument is its capability of performing
several types of MS/MS analysis:
MRM provides the best selectivity and highest sensitivity obtainable on a triple
quadrupole instrument. This helps to carry out quantitative analysis on complex
samples. The selectivity gain results from the fact that the m/z ratios of the product
ions and the precursor ions must satisfy the selected values. The sensitivity gain
results from the greater signal-to-noise ratio, characteristic of MS/MS; the chemical
noise decreases more than the ionic signal, which is smaller because of the weak ion
transmission through the instrument, due to the trajectory lengths of the ionic species
and the presence of a collision gas. In this acquisition mode, Q1 selects a specific
precursor ion and Q3 analyses a specific fragment ion after CID in Q2 (figure 17).

Thus, MRM has been extensively used throughout this research project for the
analysis of AZAs (Chapter 2 - 4).

O

Qi
Filter Precursor Ion

Q2
CID

Q3
Filter Product Ion

Figure 17. Diagram of the MRM process in a QqQ MS. Reproduced from Applied
Biosystems.

In product ion scan mode, the first mass filter, Ql, separates or filters ions according
to their m/z ratio and allows only one ion to enter Q2, where it is fragmented. The
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product ions generated are then passed into Q3 and scanned to provide a spectrum
(Figure 18). This acquisition mode has been used during this project to confirm the
identity of different biotoxins, as the spectrum showing the fragment ions of a specific
analogue is the “fmgerprinf ’ of that molecule.
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Figure 18. Diagram of the product ion scan process in a QqQ MS. Reproduced
from Applied Biosystems.

Finally, there are two other acquisition modes in tandem MS: precursor ion scan and
neutral loss scan, useful for drug metabolite detection and identification of
compounds from similar functional groups respectively.

6.

Quadrupole Ion-Trap (QIT) Mass Analysers

This analyser was first used with GC-MS instrumentation and the design and
operation of ion-trap mass analysers is very different from that of triple quadrupoles.
Whereas triple quads analyse and perform MS-MS on ions “on the fly” as they pass
through the analyser, ion traps collect and store ions in order to perform MS-MS
analysis on them. The analyser is a very simple design. The ions from the source are
directed into the ion trap, which consists of a top and bottom electrode (end caps) and
a ring electrode around the middle (Figure 19). The trap itself is about the size of a
grapefruit. Ions collected in the trap are maintained in Orbits within the trap by a
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combination of DC and radiofequency voltages. A small amount of helium is used as
a “cooling gas” to help eontrol the distribution of energies of the ions.

In full scan mode, the radiofrequency voltages on the electrodes are stepped or
scanned to sequentially eject ions on the basis of their mass to charge values. This
produces a spectrum representing all of the ions in the trap at any given time. To
monitor the ions from the source, the trap continuously repeats a cycle of 1) filling the
trap with ions, and 2) scanning the ions out according to m/z values. Thus, unlike the
triple quadrupole, the ion trap produces a series of closely spaced analyses, rather than
a continuous analysis. Like the triple quad, the ion trap detects multiply charged ions
formed by ESI, as long as their m/z values fall within the mass range limit of the
analyser. To perform MS-MS analysis, the trap fills with ions from the source. Then a
particular ion of interest is selected and the trap voltages are adjusted to eject ions of
all other similar m/z values. The voltages on the trap then are quickly increased to
increase the energies of the remaining ions, which result in energetic collisions of the
peptide ions with helium gas atoms in the trap and induces fragmentation of the ions.
The fragments then are caught in the trap and scanned out in according to their m/z
values.
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Ion Source

Detector

Figure 19. Experimental setup of the ion trap. Reproducedfrom Bruker Daltonics.

A unique feature of traps is that fragment ions from MS-MS experiment can
themselves be retained in the trap and then subjected to another round of
fragmentation. Fragments from this secondary MS-MS analysis can likewise be
retained and further fragmented. This type of analysis is referred to as MS" [129] and
can yield highly detailed fragmentation information in certain cases. There a couple
other features that distinguish ion traps from triple quadrupoles for tandem MS
analysis. The first is that fragmentation patterns generated by MS-MS ions in ion trap
can differ somewhat from those produced by triple quadrupoles.

Under the most commonly used operating conditions, traps tend to induce a much
more complete fragmentation of the precursor ion than do quadrupoles. This means
that more of the precursor ions are converted more efficiently to product ions in ion
traps. Indeed, the precursor ion signal usually is not seen in ion-trap MS-MS spectra,
whereas it often is a prominent feature of triple quad MS-MS spectra and is fair to say
that triple quads tend to induce a more diverse range of fragmentation in MS-MS than
do ion traps.
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A final difference between ion traps and triple quadrupoles is the so called “low m/z
cutoff’ for MS-MS ion traps. Owing to the way the ion trap functions for MS-MS, it
is not possible to record the masses of product ions whose m/z values are below about
25% of the m/z value of the precursor ion that was subjected to the MS-MS. Yet new
advancements in mass specrtrometry/ have allowed for intelligent analysis and by use
of Pulsed Q Collision Induced Dissociation (PQD), this now enables trapping of low
mass fragment ions and will be explained further below. One last interesting feature to
note about ion traps is that they actually are capable of very high mass resolution.
However, the resolution of the trap decreases with the speed at which ions are
scanned out and detected. If the rate of scanning is slowed, traps can resolve species
differing by as little as 0.05 units on the m/z scale.

7.

Quadrupole Time-of-Flight (Q-TOF) Mass Analyser

This is a hybrid system (explained previously) takes advantage by using two different
analysers that of a quarupole and time of flight. TOFMS is a method of mass
spectrometry in which ions are accelerated by a known strength electric field. This
acceleration result in an ion having the same kinetic energy as any other ion that has
the same charge. The velocity of the ion depends on the mass to charge ratio. The
time that it subsequently takes for the particle to reach the detector at a known
distance is measured. This time will depend on the mass-to-charge ratio of the particle
(heavier charged compounds reach lower speeds). These simple start-to-finish
analysers operated in what is referred to as “linear mode.” These ions were formed in
the MALDl source, continually extracted from the source, and then sent down the
flight tube to the detector. Unfortunately, the resolution of instruments running in
linear mode with continuous extraction of ions was relatively poor.
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The lack of resolution in linear-mode instruments is due to variations in the velocities
of ions of the same m/z as they fly down the flight tube. The problem was solved with
two important technical innovations. The first is the reflectron, the reflectron focuses
ions of the same m/z values and allows them to reach the detector at the same time.
The reflectron dramatically improved resolution of TOP analysers. Another approach
to improving the resolution of TOP analysers in linear mode is the use of pulsed-laser
ionization with delayed extraction. The delayed extraction technique involves
building a slight delay between the laser pulse (ionization) and the direction of the
ions down the flight tube. This permits the ions all to get a “fair start.” such that all

Figure 20. Schematic diagram of the tandem QqTOF mass spectrometer.
Reproducedfrom Applied Biosystems [146].

species of the same m/z will hit the detector at the same time. Spectra are obtained by
averaging the spectra obtained from many laser pulses (typically 10-100). The effect
of delayed extraction on spectral resolution is similar to that of a reflectron. The
development of TOP analyser technology has produced some of the best mass
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analysers available today. A combination of TOP and quadrupole provides superior
data quality and advanced analytical capabilities for profiling, identifying,
characterizing, and quantifying low molecular-weight compounds and biomolecules
with confidence.

The Q-TOF is functionally identical to a triple quad, except that the quadrupole Q3 is
replaced by a TOP mass analyser. In the Q-TOF, full scan and MS-MS experiments
are done in the same way as they are on the triple quad, except that the product ions in
MS-MS are analysed by the TOP mass analyser rather that the Q3. The key advantage
of the Q-TOF is that the TOP is capable of much higher mass resolution than the
quadrupole. Thus, very accurate mass measurements of product ions can be done.
These Q-TOF systems deliver exceptional MS and MS/MS analyses that support
demanding applications such as proteomics, metabolomics, impurity testing, product
degradation studies, forensics, food safety, and environmental analyses. Some of the
most recent Q-TOF’s on the market now offer a typical mass accuracy of sub-1-ppm
MS and 2-ppm MS/MS which may rival or exceed that of much more expensive
FTMS and orbitrap trapping instruments.

Enhanced mass resolution of up to 40,000 mass resolution is capable of distinguishing
target analytes from interferences. Spectral acquisition rates of up to 20 MS or 10
MS/MS spectra per second for compatibility with high-throughput, rapid-resolution
chromatography and finally a very wide time-of-flight mass range, from 20 - 20,000
m/z. A disadvantage of the Q-TOF would be that at the lower m/z range of about 100
the resolution would be very poor and so operates better at the higher end of the m/z
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range, thus its ability to resolve low molecular weight peptides in the application of
proteomics would be very poor.

8.

Linear Trap Quadrupole Orbitrap (LTQ-Orbitrap) Mass Analyser

LTQ-Orbitrap (Figure 21) has demonstrated an incredible versatility for the mass
analyses of various compound classes for both research and routine analysis. The
limited trade-off between sensitivity and resolving power plus a wide dynamic range
for mass accuracy make the LTQ Orbitrap an ideal analytical tool for structural
elucidation of metabolites. The capabilities of the LTQ Orbitrap are well harnessed
for applications like biotransformation profiling and were well suited to the study of
AZA as two bodies of work involved biotransformation of AZA within shellfish. The
ability to conduct tandem mass spectrometry coupled with accurate mass
measurements, all in a single run, is clearly one of its most attractive features [130].
The high mass resolving power of the Orbitrap mass analyser becomes very handy for
distinguishing molecular and product ions from interfering background ions.

It should be noted that mass accuracy criteria without proper mass resolution criteria
can yield false compliant (false negative) results [131]. The method developed on the
QqQ and which is well established for the analysis of AZA’s was transferred to the
LTQ Orbitrap and validated, so as to utilise exact mass measurements for metabolite
confirmation. The ability of the Orbitrap mass analyser to clearly observe an isotopic
pattern can be utilized to trigger data-dependent product ion scans. The method has a
broader detection capability compared to classical approaches utilising product ion or
neutral loss scans, since it is independent of the CID behaviour of the compounds.
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Figure 21. Schematic diagram of Linear ion Trap Quadrupole/Orbtrap XL (LTQ
XL). Reproducedfrom Thermo Scientific.

In an Orbitrap, ions are injected tangentially into the electric field between the
electrodes and trapped because their electrostatic attraction to the inner electrode is
balanced by centrifugal forces. Thus, ions cycle around the central electrode in rings.
In addition, the ions also move back and forth along the axis of the central electrode.
Therefore, ions of a specific m/z ratio move in rings which oscillate along the central
spindle. The frequency of these harmonic oscillations is independent of the ion
velocity and is inversely proportional to the square root of the mass-to-charge ratio
(m/z or m/q). By sensing the ion oscillation the trap can be used as a mass analyser.
Orbitraps have a high mass accuracy (1-2 ppm), a high resolving power (up to
200,000) and a high dynamic range around 5000 [132-133].

Probably the most useful attributes of the Orbitrap mass analyser are the high mass
resolution and mass accuracy. They are of general utility for both small and large
molecule analysis. It is the analysis of very complex mixtures where the extensive
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dynamic range and overall versatility of the LTQ Orbitrap can be truly appreciated.
The LTQ can be used as a front end for the Orbitrap. The linear ion trap uses a set of
quadrupole rods to confine ions radially and a static electrical potential on-end
electrodes to confine the ions axially [134]. The linear form of the trap can be used as
a selective mass filter, or as an aetual trap by creating a potential well for the ions
along the axis of the electrodes [135]. Advantages of the linear trap design are
inereased ion storage eapaeity, faster scan times, and simplicity of construction
(although quadrupole rod alignment is eritical, adding a quality control constraint to
their production) [136].
With Orbitrap offering high resolution and greater sensitivity, this been due to the
frequency of harmonic oscillations within the trap been independent of the ion
v eloeity, it has established itself as a leader in the areas of proteomics [137], doping
control [138-140], metabolomics [141], lipids [142] and metabolism. Another feature
adding to the Orbitraps popularity with the above mentioned is a new dissociation
technique called Pulsed Q Collision Induced Dissociation (PQD), which has been
developed by Thermo Electron and implemented exclusively for their linear ion trap
mass spectrometers [143-144]. Until now, resonance excitation CID has been the
most widely used for precursor ion activation and dissociation in ion trap mass
spectrometers.
PQD generates spectra qualitatively similar to CID, however, at the same time, it
allows the observation of low m/z fragments that are usually excluded from CID (not
possible to record the masses of product ions whose m/z values are below about 25%
of the m/z value of the precursor ion that was subjected to the MS-MS) spectra and
also helps to access higher energy dissociation channels [143-145].
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Figure 22 below shows a comparison of PQD and CID product ion spectra generated
from AZAl isolated from the HP of M. Edulis. I'he low mass cut-off typically
observed with resonance excitation CID excludes detection of low m/z fragments of
AZAl including product ions that cannot be generated via MS'’. On the other hand,
PQD provides access to these low m/z product ions, particularly, m/z 168, which may
then be used for quantification or screening purposes.

Figure 22. Comparison of MS2 PQD and MS2 CID spectra for [M+Hf of AZAl in
extract of HPfrom mussel tissue of M.edulis.

The advantage of screening the 168 ion is that after acquisition when mining your
results, the analyst will retrieve a list of masses that would have been found to
produce m/z 168, using optimised HCD energy. Therefore it is possible to know the
precursor mass from this. This is an advantage because the analyst does not have to
set up scans for each AZA in the method. There is quite a number of AZA’s and for
any new one, you would not know the mass. HCD will give the A-ring loss and as a
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result there will be other fragments so one ean then determine the structure. As water
is the most facile loss it is therefore the most sensitive. If the analyst wanted to use Hi
ring loss for quantitation, using HCD, he/she would probably have to apply more
energy to get that fragment and as a result would have to be optimised.

A disadvantage of the Orbitrap of which there would be far and few is that at 100,000
resolution the analyst would not be able to use fast liquid chromatography such as
ultra performance liquid chromatography (UPLC) for rapid method development and
fast analytical chromatography. The reason for this is that at 100,000 resolution the
number of duty cycles are limited to one per second and approximately between 20
and 25 points are need per peak which would be not achievable at this resolution. The
number of duty cycles can be increased if the resolution is dropped to 20,000 thus
resulting in four cycles per second.

Therefore as a result if you increase the resolution you loose the number of duty
cycles that the instruFuent is capable of, and if you reduce the resolution you will
effectively increase the number of cycles which will improve chromatography but not
dramatically with compromised resolution. This is where the Q-TOF has the added
advantage, at 40,000 resolution their is spectral acquisition rates for up to 20 MS or
10 MS/MS spectra per second for compatibility with high-throughput, rapidresolution chromatography. At 40,000 resolution the Q-TOF is capable of
distinguishing target analytes from interferences and so ultimately makes this a very
attractive instrument for performing rapid resolution chromatography with high mass
accuracy (sub 1 ppm MS and 2 ppm MS-MS).

66

9.

References
1. Wright, J.L.C. Food Res. Int., 28 (1995), P. 347.
2. Shimizu, Y. Ann. Rev. Microbiol., 50 (1996), P. 431.
3. Hallegraeff, G.M. Phycologia, 32 (1993), P. 79.
4. Hallegraeff, G.M. Phycologia, 32 (1993), P. 79.
5. Huss, H. Food Control, 18 (1997), P. 91.
6. Todd, E.C.D. J. Food Protec., 56 (1993), P. 69.
7. Yasumoto, T. ., Murata, M., Oshima, Y., Sano, M., Matsumoto. G.K., Clardy,
J. Tetrahedron, 41 (1985), P. 1019.
8. Botana, L.M., Vieites, J.M., Louzao, M.C., Alfonso, A. In: Nollet, L.M.L.
(Ed.), Handbook of Food Analysis, Marcel Dekker, New York, (2004), P. 991.
9. Baden, D.G. FASEB J, 3 (1989), P. 1807.
10. Satake, M., Ofuji, K., Naoki, H., James, K.J. Furey, A., McMahon, T., Silke,
.1., and Yasumoto, T. J. Am. Chem. Soc., 120 (1998), P. 9967.
11. Perl, T.M., Bedard, L.M., Kosatsky, T.M.D., Hockin, J.C., Todd, E.C.D., and
Remis, R.S. New Engl. J. Med., 322 (1990), P. 1775.
12. Bates, S.S., Bird, C.J., Freitas, A.S.W. de., Foxall, R., Gilgan, M., Hanic,
L.A., Johnson, G.R., McCulloch, A.W., Odense, P., Pocklington, R., Quilliam,
M.A., Sim, P.G., Smith, J.C., Subba Rao, D.V., 1 odd, E.C.D., Walter, J.A.,
and Wright, J.L.C. Can. J. Aquat. Sci., 46 (1989), P. 1203.
13. Wright, J.L.C., Boyd, R.K., DeFreitas, A.S.W., Falk, M., Foxall, R.A.,
Jamieson, W.D., Laycock, M.W., McCuloch, A.G., Mclnnis, P., Odense, P.,
Pathak, V.P., Quilliam, M.A., Regan, M.A., Sim, P.G., Therault, P., Walter,
J.A., Gilgan, M., Richard, D.A.J., and Dewar, D.A.J. Can. ./. Chem., 67
(1989), P.481.
14. Lewis, R.J., and Holmes, M.J. Compar. Biochem. Physiol. C. Pharmacol.
Toxicol. Endocrinol., 106 (1993), P. 615.
15. Yasumoto, T., and Yotsu Yamashita, M. J. Toxicol. Toxin Rev., 15 (1996), P.
81.
16. Moore, R.E., and Bartolini, G. J. Am. Chem. Soc., 103 (1981), P. 2491.
17. Quilliam, MA., Wright, J.L.C. (1989), The amnesic shellfish poisoning
mysitry. Anal Chem %\\?. 1053-1060.
18. Lawrence, J.F., Charbonneau, C.F., Me'nard, C. Liquid chromatographic
determination of domoic acid in mussels, using AOAC paralytic shellfish

67

poison extraction procedure: collaborative study. J. Assoc. Offic. Anal. Chem.
(1991), 74, P. 68-72.
19. Vale, P., Sampayo, M.A.M. (2001b), Domoic acid in Portuguese shellfish and
fish. Toxicon 39 (6), P. 893-904.
20. Palma, A.S. (2003), Study of an annual succession cycle of phytoplankton
assemblages in Cascais bay. Master Thesis. Fac. Cie^ncias Univ. Porto, P. 65
(in Portuguese).
21. Yasumoto, T., Maurata, M. (1985), Diarrhetic shellfish toxins. Tetrahedron
41: P. 1019-1025.
22. Hallegraeff, G.M., Anderson, D.M., Cambell, A.D. (Editor), Manual on
Harmful Marine Microalgae, Unesco, Paris. (1995), P. 1.
23. Schantz, E.J. (1986), Chemistry and biology of saxitoxin and related toxins.
Ann N Y AcadSci, 47: P. 15-23.
24. Bates, HA., Rapoport, H. (1975), A Chemical assay for saxitoxin, the paralytic
shellfish poison. J A gri Food Chem, 23: P. 237-239.
25. Sullivan, J.J., Wekell, M.M. (1984), Determination of paralytic shellfish
poisoning toxins by high pressure liquid chromatography. In: Ragelis EP (ed)
Seafood toxins, ACS Symposium Series 262. American Chemical Society,
Washington DC, P. 197-205.
26. Oshima, Y., Sugino, K., Yasumoto, T. (1998), Latest advances in HPLC
analysis of paralytic shellfish toxins. In: Natori, S.,Hashimoto, K., Ueno, Y.,
(eds). Mycotoxins andphycotoxins 88. Elsevier, Amterdam, P. 319-328.
27. Quilliam, M.A. (2003), The role of chromatography in the hunt for red tide
toxins. J Chromatography A 1000:527-548.
28. Lombert, A.M., Birdard, J.N., Lazdunski, M. Ciguatoxin and Brevetoxins
share a common receptor site on the neuronal voltage-dependent Na^ channel,
FEES letters. (1987), P. 219-355.
29. Baden, D.G., Fleming, J.A., Bean, J.A., in F.A. De Wolff (Editor), Marine
toxins, Elsevier, S., Oxford, UK. (1995), P. 141.
30. Hua, Y., Lu, W., Henery, M.S., Pierce, R.H., Cole, R.B. On-line liquid
chromatography-electrospray ionization mass spectrometry for determination
of the brevetoxin profile in natural “red tide” algae blooms, J. Chromatogr.
(1996), P. 750-115.
31.Gudger, E.W. Poisonous fishes and fish poisoning with special reference to
ciguatera in the West Indies , Am J Trop Med{\93)Q), P. 10-43.

68

32. Swift, A,, Swift, T. (1993), "Ciguatera". J. Toxicol. Clin. Toxicol. 31 (1): P.129.
33. Geller, R., Olson, K., Senecal, P. (1991), "Ciguatera fish poisoning in San
Francisco, California, caused by imported barracuda". West. J. Med. 155 (6):
P. 639-642.
34. DiNubile, M., Hokama, Y. (1995), "The ciguatera poisoning syndrome from
farm-raised salmon".
Intern. Med. 122 (2): P. 113^.
35. U.S. Food and Drug Administration (2008-02-05). "FDA Advises Seafood
Processors About Ciguatera Fish Poisoning in the Northern Gulf of Mexico
Near the Flower Garden Banks National Marine Sanctuary". Press release.
36. Schlossberg D. Infections of leisure. Third edition, 2004 ASM Press,
Washington, D.C. P. 13.
37. Rivera, V.R., Poli, MA., Bignami, GS., Prophylaxis and treatment with a
monoclonal antibody of tetrodotoxin poisoning in mice. Toxicon. Sep (1995);
33 (9): P. 1231-7. [Medline].
38. Hwang, D.F, Noguchi, T. (2007), "Tetrodotoxin poisoning". Adv. Food Nutr.
Res 52: P. 141-236.
39. Hogan C.M. (2008-12-02), "Rough-Skinned Newt Taricha granulosa".
GlobalTwitcher.com.
40. Hwang, D.F., 7'ai, K.P., Chueh, CH., Lin, LC., Jeng, S.S. (1991),
"Tetrodotoxin and derivatives in several species of the gastropod Naticidae".
Toxicon 29 (S): P. 1019-24.
41. Hwang, D.F., Arakawa, O., Saito, T., Noguchi, T., Simidu, U., Tsukamoto, K.,
Shida, Y., Hashimoto, K. (1988), "Tetrodotoxin-producing bacteria from the
blue-ringed octopus Octopus maculosus". Marine Biology 100 (3): P. 327332.
42. Noguchi, T.; Hwang, D.F.; Arakawa, O.; Sugita, H.; Deguchi, Y.; Shida, Y.;
Hashimoto, K. (1987), "Alginolyticus, a tetrodotoxin-producing bacterium, in
the intestines of the fish Fugu vermicularis". Marine Biology 94 (4): P. 625630.
43.Thuesen, E.V., Kogure, K. (1989). "Kogure 1989. Bacterial production of
tetrodotoxin in four species of Chaetognatha", Biological Bulletin, Marine
Biological Laboratory, Woods Hole 176: P. 191-194.
44. Carroll, S.; McEvoy, E.G.; Gibson, R. (2003), "The production of
tetrodotoxin-like substances by nemertean worms in conjunction with
bacteria". Journal of experimental marine biology and ecology 288 (1): P. 5163.

69

45. Hagen, N.A., du Souich, P., Lapointe, B., Ong-Lam, M., Dubuc, B., Walde,
D., Love, R., Ngoc, A.H.; on behalf of the Canadian Tetrodotoxin Study
Group (2008). "Tetrodotoxin for Moderate to Severe Cancer Pain: A
Randomized, Double Blind, Parallel Design Multicenter Study". J Pain
Symptom Manage 35: P. 420.
46. Stimmel, Barry. (2002), "12: Heroin Addiction". Alcoholism, drug addiction,
and the road to recovery: life on the edge. New York: Haworth Medical Press.
ISBN 0-7890-0553-0. ""Tetrodotoxin blocks the sodium currents and is
believed to have potential as a potent analgesic and as an effective agent in
detoxoification from heroin addiction without withdrawal symptoms and
without producing physical dependence"
47. Clayden, J., Greeves, N. (2000), pages P. 19-21.
48. Chemical Society of Japan, et al. (2005), "CSJ Award-2005 Prof. Daisuke
Uemura"
49. Chemical Society of Japan, et al. (2005), "Its structural determination
presented many difficulties. Dr. Uemura elucidated its planar structure in 1981
by repeatedly carrying out site-specific oxidative degradation and determined
the structure of the degraded products using a sample that was originally
isolated from Palythoa tuberculosa of Okinawa[n] origin."
50. Stereochemistry of Palytoxin. 4. Complete Structure, J. K. Cha, W. J. Christ, J.
M. Finan, H. Fujioka, Y. Kishi, L. L. Klein, S. S. Ko, J. Leder, W. W.
McWhorter, Jr., K. -P. Pfaff, M. Yonaga, D. Uemura, and Y. Hirata, J. Am.
Chem. Soc., 104, P. 7369-7371 (1982).
51. "Total Synthesis of Palytoxin Carboxylic Acid and Palytoxin Amide," R.W.
Armstrong, J.-M. Beau, S.H. Cheon, W.J. Christ, H. Fujioka, W.-H. Ham,
L.D. Hawkins, H. Jin, S.H. Kang, Y. Kishi, M.J. Martinelli, W.W.
McWhorter, Jr., M. Mizuno, M. Nakata, A.E. Stutz, F.X. Talamas, M.
Taniguchi, J.A. Tino, K. Ueda, J. Uenishi, J.B. White, and M. Yonaga, J. Am.
Chem. Soc., 111,P. 7530 (1989)
52. "Synthesis of Palytoxin from Palytoxin Carboxylic Acid", E.M. Suh and Y.
Kishi, J. Am. Chem. Soc., 116, P. 11205 (1994).
53. Satake, M.; Ofuji, K.; James, K. J.; Furey, A.; Yasumoto, T., New toxic event
caused by Irish mussels. In Harmful Algae, Reguera, B.; Blanco, J.;
Fernandez, M. L.; Wyatt, T., Eds. Santiago de Compostela: Xunta de Galicia
and Intergovernmental Oceanographic Commission of UNESCO: (1998); P.
468-469.
54. Satake, M.; Ofuji, K.; Naoki, H.; James, K. J.; Furey, A.; McMahon, T.; Silke,
J.; Yasumoto, T., Azaspiracid, a new marine toxin having unique spiro ring
assemlies, isolated from Irish mussels, Mytilus edulis. J. Amer. Chem. Soc.
(1998), 120, P. 9967-9968.

70

55. Taleb, H.; Vale, P.; Amanhir, R.; Benhadouch, A.; Sagou, R.; Chafik, A., First
detection of azaspiracids in mussels in north west Africa. J. Shellfish Res.
(2006), 25, P. 1067-1070.
56. Nicolaou, K. C.; Koftis, T. V.; Vyskocil, S.; Petrovic, G.; Tang, W.; Frederick,
M. O.; Chen, D.Y. K.; Yiwei, L.; Ling, T.; Yamada, T. M. A., Total synthesis
and structural elucidation of azaspiracid-1. Final assigment and total synthesis
of the correct structure of azaspiracid-1. J. Am. Chem. Soc. (2004), 128, P.
2859-2872.
57. Vilarino, N., Biochemistry of azaspiracid poisoning toxins. In Phycotoxins
Chemistry and Biochemistry, Botana, L. M., Ed. Blackwell Publishing:
Oxford. (2007); P.311-318.
58. James, K. J.; Fidalgo Saez, M. J.; Furey, A.; Lehane, M., Azaspiracid
poisoning, the food-borne illness associated with shellfish consumption. Food
Addit. Contam, (2004). 21, P. 879-892.
59. Anon., Risk Assessment of Azaspiracids (AZAs) in Shellfish, August 2006 A Report of the Scientific Committee of the Food Safety Authority of Ireland
(FSAI). Food Safety Authority of Ireland (FSAl), Abbey Court, Lower Abbey
Street, Dublin 1, Ireland. (2006).
60. EU, COMMISSION DECISION of 15 March 2002, Official Journal of the
European Communities 2002/225/EC (2002).
61. The EFSA Journal, (2009). 1306, P. 1-23
62. Satake., M. Ofuji., K. James., K.J. Furey., A. Yasumoto., T. Reguera, B. B.
Blanco, J., Fernandez, M.L., Wyatt, T. (Editor), Harmful Algae, Xunta de
Galicia and Intergovernmental Oceanographic Commission of UNESCO,
Santiago de Compostela. (1998), P. 468.
63. Satake, M., Ofuji, K., Naoki, H., James, K.J., Furey, A. McMahon, T., Silke,
J., Yasumoto, T. Azaspiracid, a new marine toxin having unique spiro ring
assemblies, isolated from Irish mussels, Mytilus edulis, J. Am. Chem. Soc.
120,(1998). P. 9967.
64. Ofuji, K., Satake. M., McMahon, T., Silke, J., James, K.J., Naoki, H., Oshima,
Y., Yasumoto, T. Two analogs of azaspiracid isolated from mussels, Mytilus
edulis, involved in human intoxication in Ireland, Nat. Tox. 7, (1999). P. 99.
65. Ofuji, K., Satake, M., Oshima, Y., McMahon, T., James, K.J., Yasumoto, T. A
sensitive and specific method for azaspiracids by liquid chromatography mass
spectrometry., Nat. Tox. 1 (1999). P. 247.
66. Ofuji, K., Satake, M., McMahon, T., James, K.J., Naoki, H. Oshima, Y.,
Yasumoto, T., Structures of azaspiracid analogs, azaspiracid-4 and
azaspiracid-5, causative toxins of azaspiracid poisoning in Europe, Biosc.
Biotech. Biochem. 65, (2001). P. 740.

71

67. K.J. James., A. Furey., M. Lehane., C. Moroney., M. Satake., T. Yasumoto., in
R.A.S. deKeo, W.J., van Egmond, H.P., Gilbert, J., & Sabino, M. (Editor),
Mycotoxins and Phycotoxins in Perspective at the Turn of the Century,,
Wageningen, The Netherlands, (2001), P. 401.
68. K.J. James, A. Furey, M. Satake, T. Yasumoto, in G.M. Hallegraeff,
Blackburn, S.I., Bolch, C.J., Eewis, R.J. (Editor). Harmful Algal Blooms
(2000), Intergovernmental Oceanographic Commission of UNESCO, Paris,
2001, P. 250.
69. James, K.J., Fidalgo Saez, M.J., Furey, A., Lehane, M. Azaspiracid Poisoning,
the Food-Borne Illness Associated with Shellfish Consumption.- A Review,
Food Addit. Contamin. 21, (2004), P. 879-892.
70. Satake, M.; Ofuji, K.; James, K.J.; Furey, A.; Yasumoto, T., New toxic event
caused by Irish mussels. In Harmful Algae, Reguera, B.; Blanco, J.,
Fernandez, M. L., Wyatt, T., Eds. Santiago de Compostela: Xunta de Galicia
and Intergovernmental Oceanographic Commission of UNESCO: (1998); P
468-469.
71. Satake, M., Ofuji, K., Naoki, H., James, K.J., Furey, A., McMahon, T., Silke,
J., Yasumoto, T. Azaspiracid, a new marine toxin having unique spiro ring
assemlies, isolated from Irish mussels, Mytilus edulis. J. Amer. Chem. Soc.
(1998), 120, P. 9967-9968.
72. Nicolaou, K.C., Koftis, T.V., Vyskocil, S., Petrovic, G., Tang, W., Frederick,
M.O., Chen, D.Y.K., Yiwei, L., Ling, T., Yamada, T. M.A. Total synthesis
and structural elucidation of azaspiracid-1. Final assigment and total synthesis
of the correct structure of azaspiracid-1. J. Am. Chem. .S'oc.(2004), 128, P.
2859-2872.
73. Nicolaou, K.C., Koftis, T.V., Vyskocil, S., Petrovic, G., Ling, T., Yamada, T.
M.A., Tang, W., Frederick, M.O. Structural revision and total synthesis of
azaspiracid-1, Part 2: Definition of the ABCD domain and total synthesis.
Angew. Chem. Int. Ed (2004), 43, P. 4318 - 4324.
74. James, K.J.; Fidalgo Saez, M. J.; Furey, A.; Lehane, M., Azaspiracid
poisoning, the food-borne illness associated with shellfish consumption. Food
Addit. Contam. 2004, 21, 879-892.
75. McCarron, P., Kotterman, M., De Boer, J., Rehmann, N., Hess, P. Feasibility
of gamma irradiation as a stabilisation technique in the preparation of tissue
reference materials for a range of shellfish toxins. Anal. Bioanal. Chem.
(2007), 387, P. 2487-2493.
76. Twiner, M.J., Bottein Dechraoui, M.-Y., Wang, Z., Mikulski, C.M., Henry,
M.S., Pierce, R. IE, Doucette, G. J., Extraction and analysis of lipophilic
brevetoxins (PbTx) from the red tide dinoflagellate Karenia brevis. Anal.
Biochem. (2007), 369, P. 128-135.

72

77. Rehmann, N., Hess, P., Quilliam, M. Discovery of new analogs of the marine
biotoxin azaspiracid (AZA) in blue mussels {Mytilus edulis) by ultraperformance-liquid-chromatography
(UPLC)
tandem-mass-spectrometry
(MSMS). Rapid Comm. Mass Spectrom. (2008), 22, P. 549-558.
78. Quilliam, M., Reeves, K., MacKinnon, S. L., Craft, C., Whyte, H., Walter, J.
A., Stobo, L., Gallacher, S. Preparation of reference material for azaspiracids.
In Proceedings of the 5‘^ International Conference on Molluscan Shellfish
Safety, Galway, Ireland, June 14-18, 2004, Henshilwood, K., Deegan, B.,
McMahon, T., Cusack, C., Keaveney, S., Silke, J.; O' Cinneide, M.; Lyons, D.,
Hess, P., Eds. The Marine Institute, Rinville, Oranmore, Galway, Ireland:
(2006), P. 111-115.
79. Satake, M., Ofuji, K., Naoki, H., James, K.J., Furey, A., McMahon, T., Silke,
J., Yasumoto, T. Azaspiracid, a new marine toxin having unique spiro ring
assemblies, isolated from Irish mussels, Mytilus edulis, J. Am. Chem. Soc. 120
(1998), P. 9967.
80. Satake, M., Ofuji, K., Naoki, H., James, K.J., Furey, A., McMahon, T., Silke,
J., Yasumoto, T. Azaspiracid, a new marine toxin having unique spiro ring
assemlies, isolated from Irish mussels, Mytilus edulis. J. Amer. Chem. Soc.
(1998), 120, P.9967-9968.
81. Nicolaou, K. C., Chen, D., Li, Y., Quan, W., Ling, T., Vyskocil, S., Koftis,
T.V., Govindasamy, M., Uesaka, N. Total synthesis of the proposed
azaspiracid-1 structure. Part 2: Coupling of the C1-C20, C21-C27, and C28C40 fragments and completion of the synthesis. Angew. Chem. (2003), 42, P.
3649-3653.
82. Nieolaou, K.C., Li, Y., Uesaka, N., Koftis, T.V., Vyskocil, S., Ling, T.,
Govindasamy, M., Qian, W., Bernal, F.; Chen, D. Total synthesis of the
proposed azaspiracid-1 strueture. Part 1: Construction of the enantiomerically
pure C1-C20, C21-C27, and C28-C40 fragments. Angew. Chem. (2003), 42, P.
3643-3648.
83. Frederick, M.O., Cole, K.P., Petrovic, G., Loizidou, E., Nieolaou, K.C.
Structural assignment and total synthesis of azaspiracid-1. In Phycotoxins
chemistry and biochemistry., Botana, L.M., Ed. Blackwell Publishing: Oxford,
(2007), P. 297-309.
84. Nieolaou, K.C., Vyskocil, S., Koftis, T.V., Yamada, Y.M.A., Ling, T.T.,
Chen, D.Y.K., Tang, W.J., Petrovic, G., Frederick, M.O., Li, Y.W., Satake, M.
Structural revision and total synthesis of azaspiracid-1, part 1: Intelligence
gathering and tentative proposal, Angewandte Chemie-International Edition
43,(2004), P. 4312.
85. Ofuji, K., Satake, M., McMahon, T., James, K.J., Naoki, H., Oshima, Y.,
Yasumoto, T. Structures of azaspiracid analogs, azaspiracid-4 and azaspiracid-

73

5, causative toxins of azaspiracid poisoning in Europe, Biosci. Biotechnol.
Biochem. (2001), 65, P. 740-742.
86. Ofuji, K,, Satake, M., McMahon, T., Silke, J., James, K.J., Naoki, H., Oshima,
Y., Yasumoto, T. Two analogs of azaspiracid isolated from mussels, Mytilus
edulis, involved in human intoxication in Ireland. Nat. Toxins (1999), 7, P. 99102.
87. M. Lehane, A. Brana-Magdalena, C. Moroney, A. Furey, K.J. James, Liquid
chromatography with electrospray ion-trap mass spectrometry for the
determination of five azaspiracids in shellfish, J. Chromatogr. A, 950, (2002)
P. 139.
88. Brombacher, S., Edmonds, S., Volmer, D. A. Studies on azaspiracid biotoxins.
II. Mass spectral behaviour and structural elucidation of azaspiracid analogs.
Rapid Comm. Mass Spectrom. (2002), 16, P. 2306-2316.
89. James, K.J., Sierra, M.D., Lehane, M., Brafia Magdalena, A., Furey, A.
Detection of five new hydroxyl analogues of azaspiracids in shellfish using
multiple tandem mass speetrometry. Toxicon (2003), 41, P. 277-283.
90. Rehmann, N., Hess, P., Quilliam, M. Discovery of new analogs of the marine
biotoxin azaspiracid (AZA) in blue mussels {Mytilus edulis) by ultraperformance-liquid-ehromatography
(UPLC)
tandem-mass-spectrometry
(MSMS). Rapid Comm. Mass Spectrom. (2008), 22, P. 549-558.
91. Diaz Sierra, M., Furey, A., Hamilton, B., Lehane, M., James, K.J. Elucidation
of the fragmentation pathways of azaspiracids, using electrospray ionisation,
hydrogen/deuterium exchange, and multiple-stage mass spectrometry. J. Mass
Spectrom. (2003), 38, P. 1178-1186.
92. Hess, P., Swords, D.P., Clark, D.W,, Silke, J.B., McMahon, T. Confirmation
of azaspiracids, okadaic acid and dinophysistoxins in phytoplankton samples
from the West coast of Ireland by liquid chromatography-tandem massspectrometry. In Harmful Algae (2002), Steidinger, K.; Landsberg, J.; Tomas,
C. R.; Vargo, G. A., Eds. Florida Fish and Wildlife Conservation Commission,
Florida Institute of Oceanography, and Intergovernmental Oceanographic
Commission of UNESCO, (2004); P 252-254.
93. Hess, P., MeMahon, T., Slattery, D. Swords, D., Dowling, G., McCarron, M.,
Clarke, D., Gibbons, W., Silke, J., O' Cinneide, M. Use of LC-MS testing to
identify lipophilic toxins, to establish local trends and interspecies differences
and to test the comparability of LC-MS testing with the mouse bioassay: an
example from the Irish biotoxin monitoring programme 2001. In Molluscan
Shellfish Safety, Proc. 4th Inti. Conf. Molluscan Shellfish Safety, Villalba, A.;
Reguera, B.; Romalde, J. L.; Beiras, R., Eds. Consellerla de Pesca e Asuntos
Marltimos da Xunta de Galicia and Intergovernmental Oceanographic
Commission of UNESCO: Santiago de Compostela, Spain, (2003); P. 57-65.

74

94. Lewis. R.J., Holmes. M.J., Alewood. P.F., Jones. A. Nat. Toxins (1994), 2, P.
56.
95. Draisci. R., Lucentini. L., Giannetti. L., Boria. P., James. K.J., Furey. A.,
Gillman. M., Kelly. S.S. J. AOAC. Int. (1998), 81, P. 441.
96. Brombacher. S., Edmonds. S., Volmer. D.A. Rapid Commun. Mass Spectrom.
(2002), 16, P. 2306.
97. Furey, A., Brana-Magdalena, A., Lehane, M., Moroney, C., James, K.J.,
Satake, M., Yasumoto, T. Determination of azaspiracids in shellfish using
liquid chromatography/tandem electrospray mass spectrometry. Rapid Comm.
Mass Spec. 16, (2002), P. 238.
98. Brombacher, S., Edmonds, S., Volmer, D.A. Studies on azaspiracid biotoxins.
11. Mass spectral behavior and structural elucidation of azaspiracid analogs.
Rapid Comm. Mass Spectrom. 16, (2002), P. 2306.
99. Quilliam, M.A., Barcelo. in D. (Editor), Applications of LC-MS in
Environmental Chemistry, Elsevier, Amsterdam, (1996), P. 415.
100. Draisci, R., Palleschi, E., Giannetti, E., Eucentini, L., James, K.J., Bishop,
A.G., Satake, M.. Yasumoto, T.New approach to the direct detection of known
and new diarrhoeie shellfish toxins in mussels and phytoplankton by liquid
chromatography-mass spQciromQiry. J Chromatogr A. 847, (1999), P. 213.
101. Draisci, R., Palleschi, E., Ferretti, E., Furey, A., James, K.J., Satake, M.,
Yasumoto, T. Development of a method for the identification of azaspiracid in
shellfish by liquid chromatography-tandem mass spectrometry. J.
Chromatogr. A. 871, (2000), P. 13.
102. Volmer, D.A., Brombacher, S., Whitehead, B. Studies on azaspiracid
biotoxins. 1. Ultrafast high-resolution liquid chromatography/mass
spectrometry separations using monolithic columns. Rapid Comm. Mass
Spectrom. 16, (2002), P. 2298.
103. Eehmann, W.D. Single series peptide fragment ion spectra generated by twostage collision-induced dissociation in a triple quedrupole. J. Am. Chem. Soc.
9, (1998), P. 606.
104. Brugger, B., Erben, G., Sandhooff, R., Wieland, F.T., Eehmann, W.D.
Quantitative analysis of biological membrane lipids at the low picomole level
by nano-electrospray ionization tandem mass spectrometry. Proc. Natl. Acad.
Sci. USA, 94, (1997), P. 2339.
105. Chen, H., Tabei, K., Siegel, M.M., Biopolymer sequencing using a triple
quadrupole mass spectrometer in the ESI nozzle-skimmer/precursor ion
MS/MS mode, J. Am. Chem. Soc. 12, (2001), P. 846.

75

106. Quilliam, M.A,, Barcelo, in D. (Editor), Applications of LC-MS in
Environmental Chemistry. Elsevier, Amsterdam, (1996), P. 415.
107. Blay, P.K., Brombaeher, S., Volmer, D.A.Studies on azaspiraeid biotoxins.
111. Instrumental validation for rapid quantifieation of AZA 1 in eomplex
biologieal matriees. Rap. Commun. Mass Spectrom. 17, (2003), P. 2153.
108. Volmer, D.A., Brombaeher, S., Whitehead, B. Studies on azaspiraeid
biotoxins. 1. Ultrafast high-resolution liquid ehromatography/mass
spectrometry separations using monolithic columns. Rapid Comm. Mass
Spectrom. 16, (2002), P. 2298.
109. Yasumoto, T., Oshima, Y., Yamaguchi, M. Occurrence of a new type of
toxic shellfish poisoning in the Tohoku district. Bull. Jpn. Soc. Sci. Fish. 44
(1978), P 1249.
110. Yasumoto, T., Murata, M., Oshima, Y., Matsumoto, G.K., J. Clardy, J.,
Ragelis. in E.P., (Editor). Seafood Toxins, Am. Chem. Soc., Symposium Series
No. 262., Washington, DC, (1984), P. 214.
111. Murata, M., Shimatani, M., Sugitani, H., Oshima, Y., Yasumoto, T. Isolation
and structural elucidation of the causative toxin of the diarrhetic shellfish
Poisoning, Bull. .Jpn. Soc. Sci. Fish. 48, (1982), P. 549.
112. James, K.J., Eehane, M., Moroney, C., Fernandez-Puente, P., Satake, M.,
Yasumoto, T., Furey, A. Azaspiraeid shellfish poisoning: unusual toxin
dynamics in shellfish and the increased risk of acute human intoxications.
Food Addit. Contam. 19, (2002), P. 555.
113. Brana Magdalena, A., Eehane, M., Moroney, C., Furey, A., James, K.J. Food
safety implications of the distribution of azaspiracids in the tissue
compartments of scallops (Pecten maximus). Food Addit. Contam. 20, (2003),
P. 145.
114. Hess, P., Nguyen, L., Aason, J. Keogh, M., Kilcoyne, J., McCarron, P.,
Aune, T. Tissue distribution, effects of cooking and parameters affecting the
extraction of azaspiracids from mussels, Mytilus edulis, prior to analysis by
liquid chromatography coupled to mass spectrometry. Toxicon. 46, (2005), P.
62-71.
115. Kogawa, A., Nomura, M., Murakami, J., Kobayashi, E. The effect of free
fatty acids upon the mouse tests of diarrhetic shellfish poisons and the
determination of the poison components. Bulletin of the Aomori Prefectural
Institute of Public Health (Japanese original) (Canadian Translation of
Fisheries and Aquatic Sciences #5485). 25, (1989), P. 11.
116. Hess, P., Butter, T., Petersen, A., Silke, J., McMahon, T. Performance of the
EU-harmonised mouse bioassay for lipophilic toxins for the detection of
azaspiracids in naturally contaminated mussel {Mytilus edulis) hepatopancreas

76

tissue homogenates characterised by liquid chromatography coupled to tandem
mass spectrometry, Toxicon. (2009), P, 1-10.
117. Aasen, J., Samdal, I.A., Miles, C.O., Dahl, E., Briggs, L.R., Aune, T.
Yessotoxins in Norwegian blue mussels (Mytilus edulis): uptake from
Protoceratium reticulatum, metabolism and depuration. Toxicon. 45, (2005), P.
265-212.
118. Hess, P., McCarron, P., Ryan, M.P., Ryan, G. Isolation and purification of
azaspiracids from naturally contaminated materials and evaluation of their
toxicological effects (ASTOX). Proceedings of the 4'^ Irish Marine Biotoxin
Science Workshop 2003, P. 18-20. Renvyle, November 7* (2003), Ireland.
119. Anon. Commission Decision 225/492/EEC, laying down detailed rules for
the implementation of Council Directive 91/493/EEC as regards the maximum
levels and the methods of analysis of certain marine biotoxins in bivalve
molluscs, echlnoderms, tunicates and marine gastropods (16.3.2002) off. J.
Europ. Commun. (2002), L75, P. 62-64.
120. Anon. Report of the Joint FAO/IOC/WHO ad hoc Expert Consultation on
Biotoxins in Molluscan Bivalves (Oslo, Norway, 26-30 September 2004).
Food and Agriculture Organization (2004), Rome, Italy, P. 31.
121. Anderson, W.A., Whelan, P., Ryan, M., McMahon, T., James, K.J. Risk
assessment of azaspiracids (AZAs) in shellfish. Food Safety Authority of
Ireland. (2001).
122. Anon. Regulation (EC) No 853/2004 of 29 April 2004 laying down specific
hygiene rules for the hygiene of foodstuffs. Ojf J. Europ. Commun. (2004),
LI39, 55ff
123. Anon. Codex Committee on Fish and Fishery Products, 26-28th September
2006, Bejing China. (2006).
124. Anon. Codex Committee on Fish and Fishery Products Working Group on
Biotoxins in Bivalve Molluscs, 10-13th April (2006), Ottawa, Canada. 2006.
125. Ueoka, R., Ito, A., Izumikawa, M., Maeda, S., Takagi, M., Shin-ya, K.,
Yoshida, M., van Soest, R.W.M., and Matsunaga, S. (2009). Isolation of
azaspiracid-2 from a marine sponge Echinoclathria sp. as a potent cytotoxin.
Toxicon 53, P. 680-684
126. Plasance, S.P., Xie, M., LeBlanc, Y., Quilliam, M.A. Analysis of domoic
acid and related compounds by mass spectrometry and gas
chromatography/mass spectrometry as N-trifluoroacetyl -O-silyl derivatives.
Biomed. Environ. Mass. 19, (1990), P. 420.
127. Brunnee, C. New instrumentation in mass spectrometr. International Journal
of Mass Spectrometry and ion Physics. 45, (1982), P. 51.

77

128. Fenn, J.J. Phys. Chem. (1984), 88, P. 4451
129. Stafford, G.C., Kelley, P.E., Syka, J.E.P., Renyolds, W.E., Todd, J.F.J.
Recent omprovements in an analytical applications of advanced ion
traptechnology. Int. J. Mas Spectrom. ton Proc. 60, (1984), P. 85.
130. Peterman, S.M., Duczak, N., Kalgutkar, A.S., Lame, M.E., Soglia, J.R.
Application of a linear ion trap/Orbitrap mass spectrometer in metabolite
characterization studies: Examination of the human liver microsomal
metabolism of the non-tricyclic anti-depressant nefazodone using datadependent accurate mass measurements. J. Am. Soc. Mass Spectrom. (2006),
17, P.363-375.
131. Nielen, M.W.F., van Engelen, M.C., Zuiderent R., Rmaker R. Screening and
confirmation criteria for hormone residue analysis using liquid
chromatography accurate mass time-of-flight, Fourier transform ion cyclotron
resonance and Orbitrap mass spectrometry techniques. Anal. Chem. Acta
(2007), 586, P. 122-129.
132. Makarov. A., Denisov. E., Lange. O., Horning. S., (2006). "Dynamic range
of mass accuracy in LTQ Orbitrap hybrid mass spectrometer". J. Am. Soc.
Ma.ss Spectrom. 17, (7), P. 977-82.
133. Makarov. A., Denisov. E., Kholomeev. A., Balschun. W., Lange. O., Strupat.
K., Horning. S., (2006). "Performance evaluation of a hybrid linear ion
trap/orbitrap mass spectrometer". Anal. Chem. 78 (7): 2113-20.
134. Douglas DJ, Frank AJ, Mao D (2005). "Linear ion traps in mass
spectrometry". Mass spectrometry reviews. 24, (1), P. 1-29.
135. Quadrupole ion trap mass spectrometry: a view at the turn of the century,
Raymond E. March, International Journal of Mass Spectrometry, (2000), P.
285-312
136. Schwartz, Jae C., Michael. W., Senko and John. E. P. Syka (June 2002). "A
two-dimensional quadrupole ion trap mass spectrometer". Journal of the
American Society for Mass Spectrometry (Elsevier Science B.V.). 13, (6), P.
659-669.
137. Olsen, J.V., de Godoy, L.M.F., Li G, Q., Macek, B., Mortensen, P., Persch,
R., Marakov, A., Lange O., Horning, S., Mann, M. Parts per milliion mass
accuracy on an Orbitrap nass spectrometry via lock mass injection into a Ctrap. Mol. Cell. Proteomics (2005), 4, P. 2010-2021.
138. Thevis, M., Kamber, M., Schanzer, W. Screening for metabolical stable arylpropionamide-derived selective androngen receptor modulators for doping
control purposes. Rapid Comm. Mass Spectrom. (2006), 20, P. 870-876.
139. Thevis, M., Kohler, M., Maurer, J., Schlorer, N., Kamber, M., Schanzer, W.
Screening for 2-quinolinone-derived selective androgen receptor agonists in

78

dopeing control analysis. Rapid Comm. Mass Spectrom. (2007), 21, P. 34773486.
140. Thevis, M., Kohler, M., Thomas, A., Maurer, J., Schlorer, N., Kamber, M.,
Schanzer, W. Determination of benzimidazole-and bicylic hydantion-derived
selective androgen receptor antagonists in human urine using LC-MS/MS.
Anal. Bional. Chem. (2008), 391, P. 251-261.
141. Griffiths, W.J., Homshaw, M., Woffendin, G., Baker, S.F., Lockhart, A.,
Heidelberger, S., Guastafsson, M., Sjovall, J., Wang, Y. Discovering
oxysterois in plasma: a window on the metabolome. J. Proteome Res. (2008),
7. P. 3602-3612
142. Ejsing, C.S., Moehring, T., Bahr, U., Duchoslav, E., Karas, M., Simons, K.,
Schevchenko, A.J. Collision-induced dissociation pathways of yeast
sphingolipids and their molecular profiling in total lipid extracts: a study by
quarrupole TOP and linear ion-Orbitrap mass spectrometry. J. Mass Spectrom.
(2006), 48, P. 976-987.
143. Schwartz, J.C. U. S. Patent 6,949,743 B1
144. Schwartz, J. C.; Syka, J.E.P.; Quarmby, S.T. The 53rd ASMS Conference on
Mass Spectrometry and Allied Topics, San Antonio, TX, June P. 5-9, (2005).
145. Thermo Electron. Pulsed Q Collision Induced Dissociation (PQD) on Linear
Ion Trap Mass Spectrometers Product .support bulletin 124 P. 1-3
146. l.V. Chernushevich. A.V. Loboda, Thomson, An Introduction to
Quadrupole-Time-qf Flight Mass Spectrometry’. J. Mass Spectrom. 36, (2001),
P. 849.

79

CHAPTER II

Distribution of
Azaspiracids in the Tissue Compartments of
Mussels {Mytilus edulis)

80

1.

Objective

The present study was undertaken to examine the distribution of AZAs in mussels (M
edulis), the affects of biotransformation, and to remove any remaining doubts
regarding the propensity of these toxins, to migrate in mussel tissues. The results
presented in this chapter show that AZA is not just localised to the hepatopancreas
(HP) of mussels, as is widely accepted, but in fact are very capable of distributing to
other tissue compartments and at significant concentrations.
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2.

Introduction

The contamination of bivalve shellfish by toxins that originate from marine
phytoplankton has serious implications for human health, and the high potency of
these toxins represents difficulties in the maintenance of high quality control [1].
Early studies on the distribution of lipophilic toxins in shellfish have all agreed that
they are mainly accumulated in the HP [2-3] and as a direct result of this; the
distribution of lipophilic toxins has received very little attention. This seems to be a
common occurrence, as other authors have found a clearly preferential accumulation
(in terms of concentration) in the HP of several bivalve species, such as the mussel M.
edulis [4-5], the bay scallop Argopecten irradians [6] and the king scallop Pecten
maximus [7]. Pillet et al., found a constant proportion of 10/1 between the
concentration of OA in the HP and in the remaining soft tissues, in M edulis, during
the toxin incorporation phase from a culture of the dinofagellate, Prorocentrum lima.

This proportion between the concentrations made the contribution to the total toxin
content of the two body fractions studied approximately equal, taking into account
that the ratio between their biomasses was around 1/6. Also bearing in mind that (a) in
the scallop A. irradians [6], the DSP toxin burden in non-visceral tissues (gonad, gills,
mantle, adductor muscle or rest of tissue) represents more than 20% of the total body
contents and (b) the fact that the anatomical distribution of other toxins varies
throughout the accumulation/depuration process [8]. From the above findings it was
clear that a specific study of the anatomical distribution of AZA toxins in the mussel
was strongly needed. There is some evidence that AZAs, unlike toxins of the okadaic
acid group, may accumulate not only in the HP, but may also occur in the gonads [9]
and rest of tissue [10-12]. However, it has been found that the distribution of a toxin
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across different organs of the same animal is very difficult to study due to problems of
cross-contamination between organs. Such contamination can happen during the
sample pre-treatment stage, e.g. freezing or cooking may damage the walls of internal
organs, thus facilitating the toxin to leach into different tissues. Cross-contamination
may also happen during the dissection stage and in fact, the HP has been shown to
contain particularly sticky fluids that can adhere to tissues, even during washing steps
[13].

Yet there is the possibility that if careful consideration to the above steps is not
adhered to, can result in some degree of distribution in the shellfish tissues, but not to
the extent observed in this study and for the feeding studies. For this experiment,
twenty shellfish which were naturally contaminated with AZA form the North West
coast of Ireland off Arranmore Island were randomly sampled. They were each
carefully dissected into three individual compartments gills, HP and rest of tissue, and
analysed for presence of AZA, its distribution and resulting hydroxylates, if any.

3.

Results and Discussion

Previous studies have shown that there is a significant effect on the concentration and
distribution of various toxin groups in a variety of molluscs and crustaceans as a result
of cooking. A considerable increase in AZA toxin concentration upon steaming fresh
mussels has been reported [13]. This increase was attributed to water loss during
steaming, which may suggest that AZA is protein bound [14], and again explain why
AZAs are in shellfish for considerably longer periods than other known toxins [14].
The AZAs binding to proteins could be a reason for the very large distribution
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observed in the various tissue compartments studied as the protein may very well act
as a chaperone for AZA movement.

3.1,

LC-MS/MS Methodology for AZA Analysis

The LC-MS/MS method employed here was a modification of first quadrupole iontrap method for the analysis of AZAl [15]. Multiple reaction MRM experiments were
carried out using two Q1/Q3 transitions for each azaspiracid: [M+H]^^ [M+HH20]^, and [M+H]'^->[M+H-H20-C9Hio02R'R^]^ (Table 1). In the method used in
this study, the four toxins, AZAl, AZA2, AZA3 and AZA6, were separated en route
to the mass spectrometer chromatographically and analysed sequentially.

Toxin

[M+Hf

IM+HH20t

IM+H-H2OA-ringf

AZAl
AZA2
AZA3
AZA6

842.5
856.5
828.5
842.5

824.5
838.5
810.5
824.5

672.4
672.4
658.4
658.4

H
CH3
H
CH3

CH3
CH3
H
11

R^

R^

H
H
H
H

H
H
H
H

Table 1. Designation of azaspiracid substituents, R*, R“, R^ and R"* and the
precursor and product ion masses used for selected MRMs.

The sequence of AZA fragmentation was revealed using MS" studies with QIT mass
spectrometer and deuteration. The initial step is a facile water loss that occurs at the
C20-C21 diol to form an epoxide, followed by a retro Diels-Alder reaction that leads to
A-ring fragmentation [16-17]. This is a critical fragmentation process in AZA analysis
when using mass spectrometry, as the fragment that is lost contains R and R
substituents, leaving an ion fragment containing R^ and R"^ substituents (Figure 2).
Since all of the known AZA structural variants involve substituents located at or
between C3 and C23, the E-ring and the C27-C28 cleavages produced nitrogenous ions
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that are characteristic of all known AZAs. The ions produced are at miz 362 and 280,
respectively, and/or their corresponding water-loss ions.
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Figure 2. The A-Ring fragmentation involving IM+H-HiO]^ ion that is critical
for distinguishing between isomeric AZAs using positive electrospray mass
spectrometry.

Thus, it proved possible to distinguish AZA isomeric pairs, AZA4, AZA5 and AZAl,
AZA6, using mass selectivity, as their product ions were different (Table 1). The first
01/Q3 transition, involving a water loss-ion, does not distinguish between isomeric
toxins and both chromatographic separation and MRM transitions were used to
distinguish between AZA isomers. Thus, the second Q1/Q3 transition, that utilises Aring fragmentation product ions, can differentiate between AZAl and AZA6 (Table
1). Using the two MRMs for each analyte, the average limits of quantitation (LOQs)
for AZAs were 0.62 - 2.1 ng/g. It should be noted that it is important to select MRM
transitions with the best signal to noise ratio rather than the highest response when it
comes to sensitivity achievement. The linear range for calibration solutions used were
1 - 1000 ng/ml, with good correlation coefficients for AZAl - AZA3, (n = 6; R^ =
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0.995 - 0.998). Sufficient AZA6 was not available for full method validation and this
toxin was determined as AZAl equivalents using the certified AZAl standard. The
chromatographic conditions were selected to ensure good resolution of all AZAs. The
elution times were AZA3 (11.7 min), AZA6 (13.7 min), AZAl (14.9 min) and AZA2
(16.8 min), (Figure 3A and 3B).

100%

AZA3
A)

AZA6

AZA2

1 0

30

50

70

90

11 0

130

150

170

r-

I—■■

190

t—'—'I—'—r-

21 0

23 0

Time, min

Figure 3A. Extracted ion chromatogram representing the LC separation of
AZAs in mussels; A) Gills, mussel #4.
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Figure 3B. Extracted ion chromatogram representing the LC separation of
AZAs in mussels; B) Gills, mussel #14.

3.2.

Distribution of Azaspiracids in Mussel Tissue Compartments

All shellfish samples used in this study were blue mussels (M. edulis), naturally
contaminated with AZAs and received from the North West coast of Ireland (County
Donegal), to study the tissue distribution of AZAs. A total of 20 mussels were
randomly sampled and the toxin profiles of three tissue compartments, the HP, gills
and remaining tissue, were analysed for each individual mussel and are shown in
figure 4. While concentrations (pg/g) for each individual shellfish (n=20) in HP, gills
and remaining tissue can also be seen in tables 3, 4 and 5. It is apparent that there can
be significant variation in the total level of AZAs between individual mussels from
the same sample batch (Figure 4).
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Although the overall toxin concentrations were greatest in the HP, this part
represented only 13 % iv/w of total mussel tissues, with the gills (14 % w/w) and
remaining tissue (73 % w/w). The ranges of AZAs in the HP were: AZAl (0.02 - 5.0
pg/g), AZA2 (0.12-1.9 pg/g), AZA3 (0.06 - 0.88 pg/g), and AZA6 (0.05 - 2.0 pg/g)
(Table 2). Hydroxyl and carboxyl analogues were also detected but at low
concentration levels (< 2 % of total AZAs).
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Figure 4. The distribution profiles of AZAs in hepatopancreas, adductor mussel
or rest of tissue and gills of 20 mussels.
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Tissue
Compartment
Hepatopancreas
Gills
Remaining
Tissue

%Total

AZAl

AZA2

AZA3

AZA6

Mass
13
14
73

(^ig/g)
1.17
0.250
0.107

(^g/g)
0.507
0.094
0.033

(Mg/g)
0.540
0.080
0.047

(Mg/g)
0.320
0.041
0.017

Total
AZA
(^g/g)
2.537
0.465
0.204

AZA (%)
Distribution
60.6
12.0
27.4

Table 2. Mean AZAs distribution in the tissue compartments of mussels (M.
edulis.).

HEPATOPANCREAS1 (lig/g)
SHELLFISH AZA 1
AZA 2
AZA 3
1
0.46
0.13
0.73
2
1.64
0.69
0.41
3
0.62
0.32
0.45
4
0.17
0.36
0.83
0.32
5
0.21
0.76
6
0.015
0.10
0.35
1.41
7
0.63
0.47
0.79
8
2.51
0.24
9
1.21
0.64
2.84
10
1.01
0.45
0.55
11
0.12
0.12
0.88
12
0.23
0.17
0.50
13
0.43
0.26
0.57
14
0.064
0.52
0.47
15
0.11
0.12
0.49
16
0.46
0.35
0.27
17
0.82
5.01
1.90
18
0.50
0.28
0.70
19
0.22
0.51
0.23
20
4.63
1.54
0.57
TOTAL AZA
23.4
10.1
10.8

AZA 6
0.051
0.19
0.091
0.087
0.053
0.063
0.11
0.79
0.37
0.30
0.045
0.050
0.050
0.35
0.054
0.16
1.18
0.28
0.080
2.03
6.4

Table 3. Mass concentration of AZAl, AZA2, AZA3, and AZA6 in
hepatopancreas for 20 shellfish.
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SHELLFISH
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
TOTAL AZA

GILLS (jig/g)
AZA 2
AZA 1

AZA 3

AZA 6

0.021
0.061
0.052
0.010
0.0071
0.020
0.039
0.30
0.19
0.08
0.0042
0.028
0.013
0.070
0.018
0.073
0.36
0.072
0.027
0.42
1.9

0.11
0.078
0.089
0.11
0.08
0.072
0.059
0.054
0.056
0.055
0.072
0.053
0.065
0.032
0.077
0.050
0.15
0.10
0.10
0.12
1.6

0.051
0.045
0.042
0.073
0.040
0.043
0.030
0.040
0.033
0.030
0.034
0.033
0.039
0.021
0.036
0.038
0.041
0.044
0.050
0.040
0.80

0.0058
0.15
0.052
0.0080
0.044
0.046
0.078
0.94
0.44
0.23
0.046
0.037
0.038
0.15
0.0026
0.11
1.21
0.20
0.0091
1.39
5.2

Table 4. Mass concentration of AZAl, AZA2, AZA3, and AZA6 in gills for 20
shellfish.
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Remaining Tissue (^g/g)
SHELLFISH AZA 1
AZAl
AZA 3
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
TOTAL AZA

0.0049
0.14
0.045
0.04
0.037
0.0062
0.066
0.27
0.27
0.093
0.0070
0.017
0.021
0.17
0.0085
0.063
0.65
0.017
0.018
0.21
2.1

0.0030
0.036
0.018
0.014
0.0077
0.0030
0.025
0.095
0.088
0.033
0.0030
0.0081
0.0043
0.046
0.0041
0.018
0.18
0.0076
0.0057
0.056
0.65

0.033
0.044
0.033
0.10
0.10
0.025
0.039
0.024
0.044
0.045
0.054
0.044
0.072
0.026
0.024
0.038
0.090
0.039
0.039
0.025
0.93

AZA 6
0.011
0.011
0.011
0.042
0.033
0.012
0.0091
0.011
0.015
0.015
0.017
0.018
0.029
0.013
0.0099
0.013
0.028
0.012
0.016
0.0068
0.33

Table 5. Mass concentration of AZAl, AZA2, AZA3, and AZA6 in remaining
tissue for 20 shellfish.

The concentration of AZA6 was generally low in the gills and the remaining tissue
but 5 mussels of the 20 analysed contained significantly high levels (0.34 - 2.0 ^g/g)
of this toxin in the HP. (Figures 3 A and 3B) shows the extracted ion chromatograms
obtained, using extracts from the gills of two mussels (mussel #4 and #14) and
demonstrates the significant differences in their toxin profiles. AZA3 and AZA6 are
usually present at levels that are much lower than AZAl but this is not the case in the
gills of mussel #4 (Figure 3A). For instance, figure 3B shows the typical AZA profile
that one would expect to see in mussels, that is AZAl present at approximately 70%,
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\ZA2 30% and AZA3 at 10% of the total AZA content. This type of profile is
considered the normal for AZAs presence in mussels but the results from figure 3A
show a different type of distribution. As can be seen from the chromatogram, figure
3A, AZA3 has elevated almost five-fold and AZA6 three-fold when compared to the
profile expression for figure 3B. This we believe to be due to a process of
demethylation which is as a result of biotransformation taken place within the
individual compartments of shellfish. This result was not just an observation seen in
five or ten shellfish but in actual fact was found in as many as 40 to 50 that were
analysed individually. Interestingly, this profile was observed the most in the gills and
HP compartments and to a lesser extent in the rest of tissue.

One has to remember that the gills may be the first point of contact with AZA toxin,
and so may localise here to begin with and then quickly distribute throughout the
shellfish i.e. rest of tissue and finally concentrating in the HP, which then act as the
storage depot for the toxin. It is perfectly acceptable that AZA will reside in the HP
and thus be most concentrated, after all this is the liver and its function is to detoxify
and biotransform harmful xenobiotics, such as AZA. Hess et al, has reported that it is
the HP, and HP only that should be monitored for the presence of AZA [18] and all
other tissues to be discarded. These results presented here clearly show that is not a
true appraisal and that there is great need for monitoring each compartment, in order
to ascertain an overall true representation of the total concentration of AZAs.

As expected, AZAs levels, expressed as pg/g (Table 2), were much higher in the HP,
when compared to the gills and remaining tissue. However, since the average mass of
the HP of mussels represented only 13% of the total shellfish mass, the other tissue
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compartments contributed significantly to the overall toxin content. Taking into
account the mass distribution of the tissue compartments of mussels, the average total
AZA distribution was HP (60.7%), adductor muscle (27.4%) and gills (12.0%) (Table
2). As far as we are aware, this is the first report demonstrating that AZAs can be
found at significant levels in the gills of mussels.

Mussels (M edulis) appear to behave differently from other shellfish species and
produce a much greater number of AZA analogues, such as the 3-hydroxy and the 23hydroxy analogues of AZAl, AZA2, AZA3 and AZA6, that were first identified in
our previous studies [19] as well as 22-carboxy-AZA3 (AZA 17) and 22-carboxyAZA6 (AZA 19) [20]. It is probable, that these hydroxyl and carboxyl analogues are
mussel biotransformation products. In an earlier study, the possibility of significant
migration of AZAs in mussel tissues was observed and suggested that this led to
human intoxication incidents, since the regulatory practice at that time was to
examine only the HP of mussels for toxins, using a mouse bioassay [11]. Hess et al.
attempted to refute the data presented previously by suggesting, that the toxin content
that was reported in the non-HP part of the mussel tissues was a consequence of
repeated errors in shellfish dissection [20].

However, this is not a logical assertion as our data clearly showed that the mean AZA
profiles were different in these tissue compartments. Very low levels of AZAs (0.02 0.18 pg/g whole tissue) were present in shellfish used for the study by Hess et al.,
which precludes any serious conclusions with respect to AZA distribution. In fact,
most of the shellfish used in the latter study would have been classified as ‘safe for
human consumption’ under existing EU regulations. The migration of AZAs to
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mussel tissues, other than the HP, may affect the rates of depuration and there is
evidence that binding to specific proteins may be involved in the transport of AZAs in
mussels [14].

4.

Conclusions

The distribution of AZAs in the tissue compartments of mussels reported in this study
once again demonstrates the importance of using extracts from the whole shellfish
rather than just the HP, to obtain a true appraisal of total AZA toxin profile and
content in mussels. This study has also revealed that the distribution of AZAs in
mussel tissue compartments is complex and that the gills contribute significantly to
the overall level of these toxins in mussels. The work has proven that AZA is not just
localized to the HP of mussels as which is widely accepted, but in fact very capable of
distributing to other tissues and at significant concentrations. When the mass
distributions for each mussel compartment were compared, it was observed that the
gills had 12% of the overall toxin content, this is a significant concentration and again
highlights the importance of using total tissues for AZA determination as oppose to
just the HP compartment. More importantly we believe that this is the first reported
incidence of AZAs presence in the gill compartment and at such significant
concentrations. The influence of AZAs has great importance from a commercial point
of view, and so when performing the extraction procedure great care should be taken
for each step to avoid false positives. The total tissue should be used to avoid falling
under the regulatory limit set by the European union of 160 pg AZAs equivalents per
kg shellfish flesh [21].
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5.

Future Work

Future work that can be conducted in this area could be as follows, during feeding
study’s performed on shellfish such as M Edulis, it would be interesting to monitor
environmental conditions to see if there is a direct impact on mussel uptake and
distribution of AZA by changing factors such as light intensity, exposure, salinity,
temperature, etc. This would demonstrate the optimum climatic conditions for feeding
of AZAs and may also show increase or decrease or even no change in the rate of
distribution within the mussel itself

6.

Materials and Methods

6.1.

Toxin Standards and Chemicals

AZAs, AZA 1-AZAS and AZA6, were isolated from mussels (M edulis), that were
collected from County Donegal (northwest Ireland), using procedures previously
described (Ofuji et ciL, 1999) and confirmed using authentic standard toxins kindly
provided by Prof M. Satake, Tohoku University, Sendai, Japan. A certified reference
standard AZAl, CRM-AZAl (1.24 ± O.OTpg/ml; NRC, Halifax. Canada), was used
for calibrations studies. HPLC grade acetonitrile and water were purchased from
Labscan (Dublin, Ireland) and formic acid from Sigma-Aldrich (Dublin, Ireland).

6.2.

Extraction of Shellfish Tissues

Mussel tissues (M edulis) from 20 individual shellfish, harvested in County Donegal,
Ireland, were randomly sampled from a 50kg batch. Tissues were dissected into HP,
gills and remaining tissue and each were analysed separately. Shellfish tissues, HP,
gills and remaining tissue, were separately homogenised (Ultra Turrax, IKA,
Germany) with acetone (4 ml) in a 50 ml centrifuge tube for 1 min, followed by
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centrifugation at 700 g for 3 min. The supernatant was transferred to a volumetric
flask (10 ml), the extraction procedure was repeated and combined with the first
extract and the flask was made up to 10 ml. An aliquot (1 ml) was evaporated using
nitrogen at 40 °C (TurboVap, Zymark, MA, USA). To the remaining residue, water
(0.5 ml) and ethyl acetate (2 ml) were added with vortex mixing for 1 min. The
solution was centrifuged at 700 g for 3 min and the ethyl acetate was transferred to a
glass tube (10 ml). The extraction with ethyl acetate (2 ml) was repeated and the
combined extracts were evaporated using nitrogen. The residue was reconstituted with
acetonitrile (200 pi) using sonication and vortex mixing and this solution (3 - 5 pi)
was used for LC-MS/MS analysis.

6.3.

Liquid chromatography- Mass Spectrometry (LC-MS/MS)

Analysis of AZAs were performed on an Agilent 1100 series HPLC system (Agilent,
Palo Alto, CA, USA) linked to a triple quadrupole mass spectrometer (API 3000,
Applied Biosystems, Warrington, UK), equipped with turbo-assisted lonspray
electrospray ionisation (ESI) source, in positive mode. Analyst 1.5 software was used
for instrument control, data acquisition and data analysis. The sample vials were
maintained at 4 °C in the thermostatic autosampler prior to analysis. Chromatographic
separation was obtained using isocratic elution (acetonitrile/water (58:42, v/v)
containing 0.05 % formic acid) on a reversed phase column (Luna-C18 (2), 5 pm, 150
X 2.0 mm; Phenomenex, Macclesfield, UK) at 35 °C and at a flow rate of 200 pl/min.
The injection volume was 1 pi and the eluent flow was diverted to waste for 1 min
after sample injection using a switching valve. MS detection was carried out during 125 min of the chromatography. Multiple reaction monitoring (MRM) was used for the
simultaneous analysis of AZAl, AZA2, AZA3 and AZA6 and quantitation was
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related to a certified standard, CRM-AZAl (1.24

±

0.07 ^ig/ml; NRC, Halifax,

Canada). For each toxin, two transitions were monitored; [M+H]^ ^ [1VI+H-H20]^
and [M+H]^

[M+H-H20-Aring]^ (Table 1). The hydroxyl analogues, AZA4,

AZA5, AZA7 - AZA12, and carboxyl analogues, AZA17, AZA19, were also
monitored in all extracts, but if present, they were found at combined concentrations
<2 % of total AZA content.

The ion source dependant parameters were optimised for AZA1-AZA6 as follows;
nebuliser gas (NEB) 10 (arb), curtain gas (CUR) 15 (arb), ionspray voltage (IS) 4250
V, temperature (TEM) 550 ®C, and collision gas (CAD) was set to 5 (arb). The MRMs
were performed with low resolution to achieve the highest sensitivity and all Ql/QS
pairs had a dwell time of 100 msec, leading to a total scan time of 0.315 sec. The
optimised instrument parameters were, declustering potential (60 V), focusing
potential (300 V), entrance potential (10 V) and cell exit potential (18 V). For the
[M+H]^

[M+H-H20|^ transition, collision energy (45 V) and for the [M+H]^

->

[M+H-H20-Aring]^ transition, collision energy (70 V).
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CHAPTER III

Biotransformation of azaspiracid-1 in Blue Mussel (Mytilus
edulis): Identification of a Rare C-Deniethylation Mechanism
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1.

Objective

The aim of this study was to identify the means by which azaspracid-1 (AZAl)
undergoes bioconversion in the mussel, M. edulis. In order to conduct this research,
live mussels had to be collected, stored in salt water tanks and depurated for up to one
year to ensure that all mussels used for feeding experiments were completely clear
from all AZAs (see materials and methods section). These feeding experiments
proved successful and it was observed that AZA1 undergoes a rare C-demethylation
via the formation of a carboxylate intermediate. Overall the main objective of this
investigation was to identify AZAl bioconversion products and pathways in mussels
(M edulis).
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2.

Introduction

Foreign and potentially toxie compounds absorbed into biological systems such as
mussels, are generally lipophilic substances. They are therefore not ideally suited for
excretion, for example, AZA is a lipophilic substance and is poorly excreted and
therefore can remain in the molluscan biological system for many months [1]. In the
biotransformation of xenobiotics, the biological system attempts to convert such
lipophilic substances into more polar, and consequently, more readily excreted
metabolites. The exposure of the biological system to the compound is hence reduced
and potentially toxicity decreased. This process of biotransformation is therefore a
crucial aspect of the disposition of a toxic compound in vivo. The metabolic fate of a
compound can therefore have an important bearing on its toxic potential, distribution
within the organism and eventually excretion.

When a study performed by Furey et cil, [2] which identified for the first time the
presence of AZAs in other bivalve molluscs, including oysters {Crassostrea gigas),
scallops {Pecten maximus), clams {Tapes phillipinariumj and cockles {Cardium
edule), it was noted that none of the bivalves analysed showed any presence of AZA3
and thus a different profile from that of M edulis. Also as will be seen in chapter IV,
a feeding study was performed where AZAI-AZA3 and AZA6 were administered to
mussels and the results found proved very promising, in that there was a decrease of
AZAl and AZA2 content and an increase in the concentration of AZA3 and AZA6.
When analysed, the concentration of AZA3 and AZA6 had increased almost 3 fold
and this was believed to be as a result of demethylation. The mussel, M edulis, has
the profile of AZAl, KZA2 and also AZA3, which was not seen in the study
performed by Furey et al, and in contrast with our own AZA1-AZA3 and AZA6 feed
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study we hypothesized that the mussels must be performing some form of
biotransformation and what ultimately was the basis for this study. Rundberget et al.
[3] recently suggested that AZA3 and AZA6 are products of metabolic conversion in
mussels, because only AZAl and AZA2 were detectable by LC-MS in water samples
while the mussels collected from the same site contained high levels of AZA1-AZA3,
and AZA6. On the basis of these considerations, we proposed that AZAl7 is 22carboxy-AZA3, produced by oxidative metabolism of the 22-methyl of AZAl in the
mussel, and that heating AZAl7 eliminates CO2 from the 22-COOH to generate
AZA3, (Figure 7). This proposal also predicts that the levels of AZA6 will also
increase through an equivalent series of transformations via AZAl9 and is the basis
for chapter IV, studying the biotransformation of AZA2. Provided that AZAl7 and
AZAl9 decarboxylate under mild conditions to produce AZA3 and AZA6, this would
provide an explanation for the absence of AZA3 and AZA6 in seawater [3] as well as
for the increase in AZA3 as a result of heating (Figure 7).

To investigate whether AZAl7 was firstly as a result of biotransformation of AZAl
and secondly the intermediate responsible for the production of AZA3, all samples
were screened using an LTQ Orbitrap XL mass spectrometer (MS) instrument. The
LTQ mass analyser provided MS" spectral data and the Orbitrap mass analyser
provided high resolution MS data. Once the fragmentation path was established these
transitions were then added to the existing method on the QqQ where all samples
were again screened for the presence of AZAl7 and all found to be positive (Figure
6). Table 1 represents the precursor and product ions selected for the determination of
AZAs using MRM mass spectrometry analysis on QqQ, these transitions (AZAl7 and
AZAl9) were only possible through the capabilities of the LTQ Orbitrap XL mass
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spectrometer. However, biotransformation may not always increase water solubility.
For example, many sulfonamide drugs are acetylated in vivo, but the acetylated
metabolites can be less water soluble, precipitate in the tissue compartments, and
cause toxicity. As the chemical structure is changed from that of the parent
compound, there may be consequential changes to the pharmacological and
toxicological activity of the compound. For some compounds, the pharmacological
activity resides in the metabolite rather than the parent compound. Although
biotransformation is usually regarded as a detoxification process, this is not always so
as is with the production of AZA3 which is more toxic than AZAl [4] Thus the
pharmacological or toxicological activity of the metabolite may be greater or different
from that of the parent compound. Metabolism, is therefore an important determinant
of the activity of the compound, the duration of the activity, and the half-life of the
compound in the body.

Enzymes, some of which are specific for the metabolism of xenobiotics, catalyse the
metabolism of foreign compounds [5]. The metabolic pathways involved may be
many and various but the major determinants of which transformations take place are
the structure and physicochemical properties of the compound in question and the
enzymes available in the exposed tissue [5]. The resulting biotransformation of AZAl
to AZA3 via the decarboxylation of AZAl7, we believe to be as a result of the
cytochrome P-450 family of enzymes, which are phase 1 enzymes, drug metabolism
is commonly divided in Phase 1 and Phase II. Phase 1 is the alteration of the original
foreign molecule so as to add on a functional group, which can then be conjugated in
phase 2 [6]. These enzymes are a superfamily of more than 160 known members that
play a major role in the metabolism of numerous physiological substrates, as well as.
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a wide array of xenobiotics including drugs, chemical carcinogens, insecticides,
petroleum products and other environmental pollutants. Oxidative metabolism
catalyzed by cytochrome P-450s can result in detoxification or biotransformation of
xenobiotics such as AZA, Each tissue has a unique P450 gene expression, the
expression of cytochrome P-450’s is increased by several xenobiotics, as well as,
endogenous compounds such as fatty acids and steroids [6]. Multiple forms of
cytochrome P-450 have previously been determined in microsomes from the digestive
glands of Cyrptochiton stelleri [7] and also a partial purification of cytochrome P-450
form the digestive gland microsome of the common mussel M. edulis [8].
Biotransformation enzymes were monitored in the mussel M edulis from an oil spill
along the Galician coast, where an induction of the hepatic cytochrome P4501A
(CYPl A) was used as a specific biomarker for the exposure to organic pollution [9].

The enzymes involved in biotransformation also have a particular subcellular
localization, many are found in the smooth endoplasmic reticulum, some are located
in the cytosol, and a few are found in other organelles such as the mitochondria.
These subcellular localizations may have important implications for the mechanism of
toxicity of compounds. Enzymes specifically involved in the metabolism of foreign
compounds are necessarily often flexible, and the substrate specificity is generally
broad. However it follows from the above that if the structure of a foreign compound
is similar to a normal endogenous molecule, then the foreign compound may be a
suitable substrate for an enzyme primarily involved in intermediary metabolic
pathways if the enzyme is present in the exposed tissue. Thus, foreign compounds are
not exclusively metabolised by specific enzymes [5]. The organ most commonly
involved in the biotransformation of foreign compounds is the liver. AZAs are taken
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into shellfish via filter feeding and are largely localised in the liver. Therefore the
liver represents a portal to the tissues of the shellfish and is exposed to foreign
compounds at higher concentrations that most other tissues. Detoxication in this organ
and possible removal by excretion are therefore protective measures and the role of
the liver in endogenous metabolism and its structure make it an ideal site for the
biotransformation of xenobiotics [6]. It is understood that metabolism in the liver may
be so extensive during the first pass of the compound through the organ that little or
none of the parent compound may reach surrounding tissues. However, most other
organs and tissues posses some metabolic activity with regard to foreign compounds
and in some cases may be quantitatively more important than the liver, for instance
the gills.

It has been found that P-glycoprotein (p-gp) in the gills of oysters, Crassostrea
virginica has been used as a biomarker for pollution exposure and as a result p-gp has
been found to be over expressed in mussels from degraded areas. Interestingly, it was
observed from this study that p-gp expression was maximal during the warmer
months and decreased during the cooler months. AZA activity is heightened during
the warmer months and decreases during the cooler months, this may also suggest that
p-gp activity is been expressed at this time and could result in the first means of
biotransformation of AZA [10]. Although other bivalve shellfish (oysters, scallops,
cockles and clams) and crustaceans can accumulate AZAs, only mussels have so far
been associated with AZA poisoning in humans. In addition, only AZAl and AZA2
are found in most shellfish species but the AZA toxin profiles in mussels are much
more complex with multiple AZA analogues frequently present [11].
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3.

Results and Discussion

3.1.

AZAl Feeding Experiments

The feeding experiments were designed to efficiently administer AZAl to mussels
(M edulis) so that the distribution of this toxin, and its bioconversion products, in
three mussel tissue compartments could be determined using sensitive LC-MS/MS
methods. Mussels were maintained in a tank (10 L) of seawater at 14 °C and the study
was conducted over a 13-day period (Figure 1).

A)

Figure I. AZAl feeding experiment, A) represents the feed tank for AZAl
administration and B) control tank.

Firstly an experiment was conducted with the aim of establishing the rate of toxin
clearance and uptake by mussels. AfEer administering an algal feed containing AZAl,
an aliquot (50 mL) of tank water was removed for toxin analysis every hour over a 12
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hour period. This demonstrated that most of the AZAl (> 95 %) had been consumed
by mussels in 5 h. AZAl (30 pg) was administered to M edulis (10 shellfish) for the
bioconversion study at the rate of 3 pg/day, by mixing the toxin with an algal feed.
Twenty four hours after each toxin administration, the tank water was changed and an
aliquot (50 mL) was retained for toxin analysis. After 10 days, six shellfish were
removed, dissected into three parts, HP, gills and remaining tissues (predominantly
posterior adductor muscle and mantle).

The 18 tissue samples were individually homogenized and extracted immediately (See
Section 6, Materials and Methods). Targeted AZAs (14 analogues) were determined
in each sam.ple by LC-MS/MS using a triple quadrupole mass spectrometer (API
3000, Applied Biosystems). The MRM method employed monitored two precursorproduct ion transitions with optimized collision energies for 14 AZAs (Table 1). The
remaining four mussels were administered algal food daily, together with a total
seawater change, for another three days after which they were similarly dissected and
analysed for AZAs.
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Toxin

IM+Hf

AZAl
AZA2
AZAS
AZA4
AZAS
AZA6
AZAl
AZAS
AZA9
AZA 10
AZAll
AZA 12
AZAll
AZA 19

842.5
856.5
828.5
844.5
844.5
842.5
858.5
858.5
858.5
858.5
872.5
872.5
872.5
886.5

IM+HH2or

IM+H-H2Oco2r

IM+H-H2i
A-ringf

IM+H-H20C02-AringJ^

672.4
672.4
658.4
658.4
674.4
658.4
672.4
688.4
658.4
674.4
672.4
688.4

824.5
838.5
810.5
826.5
826.5
824.5
840.5
840.5
840.5
840.5
854.5
854.5
810.5
824.5

658.4
658.4

Table 1. Precursor and product ions selectedfor the determination of AZAs using
MRM mass spectrometry analysis.

3.2.

AZAl Bioconversion Products in Mussels

Figure 2 shows the main AZA toxin profiles in three mussel tissue compartments, a)
after 10 days with daily AZAl feeding, and b) after 13 days (three additional days
with no AZAl feeding). The predominant toxin identified in each tissue compartment
was AZA3 and AZA 17 (22-carboxy-AZA3) was also present (16.8% over 6SF and
14.8% over 4SF) in all samples. Full toxin profile data are presented in table 2 and
table 3. The main differences between the two data sets were a decrease in the
combined AZAl, AZA3 and AZAl7 content in the gills and an increase of AZA3
content in the remaining mussel tissues where it was the predominant toxin.
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Gills

Figure 2. Barcharts showing the distribution of AZAl, AZA3 and AZA17 after
feeding AZAl to mussels (M. edulis), A) after 10 days, B) after 13 days (no further
feeding of AZA1)

AZASPIRACID PERCENT AND RANGE FOR SIX SHELLFISH

AZAl

AZA3

AZA17

HP

GILLS

MEAT

Mean%

4.3

11.2

7.6

Range %

2.8-8.0

7.5-20.5

4.2-13.6

Mean%

7.8

30.9

21.2

Range %

5.0-9.9

25.9-37.1

11-28.6

Mean%

3.0

9.3

4.5

Range %

1.4-6.6

6.1-13.2

2.1-7.1

Table 2. Mean distribution and ranges ofAZAs in mussel (M. edulis) tissue
compartments (6 mussels, Day 10) after daily feeding of AZA1.

AZASPIRACID PERCENT AND RANGE FOUR SHELLFISH

AZAl

AZA3

AZA17

HP

GILLS

MEAT

Mean%

3.3

7.2

6.4

Range Yo

1.4-4.5

6.0.8.7

3.0-8.5

Mean%

9.6

22.4

35.8

Range%

5.7-13.8

18.5-29.3

30.3-42.3

Mean%

2.6

5.8

6.4

Range %

1.8-3.3

5.1-6.6

5.2-8.0

Table 3. Mean distribution and ranges of AZAs in mussel (M. edulis) tissue
compartments (4 mussels, Day 13) without further feeding of AZA1.

These differences may be due to toxin migration or further biotransformations. The
most significant conclusion from these studies is that this is the first proof that AZAl
is converted to AZA3 in mussels, a remarkable C-demethylation (Figure 3). Further,
the predominant intermediate in this biotransformation has been identified as AZAl7
(22- carboxy-AZA3). Other AZAs that were detected included the 3-hydroxy and 23hydroxy analogues of AZAl (AZA7, AZAS, respectively) and AZA3 (AZA4, AZA5,
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respectively). AZA4/AZA5 were found at concentration levels less than 2 % of total
AZAs and even lower concentration levels (< 0.3 %) of AZA7/AZA8 were observed.
AZA4 and AZA5 are the only hydroxylated AZA analogues that have been fully
structurally characterized using NMR spectroscopy. This study has also provided the
first confirmation that AZA4 and AZA5 are biotransformation products of AZAl in
M edulis. Also, it is reasonable to conclude that C-demethylation of AZAs in M
edulis is a more facile process than hydroxylation since the concentrations levels of
AZA3 and AZA 17 were consistently much higher than the hydroxylated AZA
analogues in all mussel tissues. The widespread distribution of AZAs in shellfish
tissue compartments that was observed in these studies are in marked contrast to other
studies using the polyether marine toxins, including OA and YTX. Suzuki et al.,
found that these toxins, and their bioconversion products, were concentrated
exclusively in shellfish HP [12].
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Figure 3. Proposed mechanism for the biotransformation of AZA1 to AZA3.
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3.3.

Evidence For The Proposed AZA17 Structure

The fragmentation pathways of the protonated AZA molecules have been well
established using a combination of MS" and high resolution mass spectrometry,
providing high mass accuracy confirmation of product ions [13]. The interpretation of
these mass spectral data was facilitated by a charge remote fragmentation process,
with a positive charge located on nitrogen in ring-J, and involves sequential rupture of
the carbon skeleton, commencing at the A-ring and continuing to the H-ring (Figure
4) [13]. LTQ-Orbitrap MS/MS data was kindly conducted by Zuzana Skrabakova, in
PROTEOBIO.
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Since AZA17 has not been isolated and fully structurally characterized using NMR, a
high resolution mass spectral study of this compound was undertaken. Using an LTQ
Orbitrap XL mass spectrometer instrument, the linear ion-trap mass analyser provided
MS" spectral data and the Orbitrap mass analyser provided high resolution MS data.
An additional feature of this MS configuration is the multipole collision cell adjacent
to the Orbitrap mass analyser which permits higher energy collisionally activated
dissoeiation (HCD) with efficient capture of product ions over an extended mass
range. Figure 5 shows the MS spectrum of AZA17 in a sample of mussel gills from
this feeding study and the mass fragmentation processes are also shown in this figure.
The mass errors (ppm), shown in bold parenthesis, were usually less than 1 ppm
(mean error = -0.33 ppm) and provided confirmation of the proposed product ion
formulae.

An important additional feature of high resolution MS is that it allows the detection of
target analytes in full-scan MS using very narrow mass isolation windows (0.002
mmu). This not only increases detection sensitivity, mainly by background reduction,
but provides better quantitative data for metabolites in the absence of analytical
standards since there are no fragmentation processes that may amplify differences
between the various analogues. LC-MS, using high resolution full-scan MS, was
applied to the quantitation of AZAs, including the labile analogue, AZA17, and
confirmed the MRM data generated using triple quadrupole MS (Figure 6).
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Figure 6. Sample chromatograms showing the AZA composition in mussel (M.
edulis) after feeding AZAl, where A) digestive glands, B) remaining tissues and C)
gills.
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The position of the carboxyl moiety on the E-ring at C-22 of AZA17 was confirmed
as follows;
a) The high resolution mass spectral data for AZA17 showed an E-ring fragmentation
product ion at m/z 362, demonstrating that the 24-methyl substituent remained intact.
b) AZA17 was formed in mussels to which AZAl (which contains a 22-methyl
substituent) was administered.
c) Finally, AZAl7 was isolated from mussel tissues and heated at 80 °C in
acetonitrile/water (50/50; v/v) for 15 min.

Analysis of this solution using the LTQ Orbitrap MS with full-scan MS and HCD
MS/MS showed a 93 % decrease in AZAl7 concentration. Comparison of
chromatographic retention times with an authentic standard showed that AZA3 was
the main product (58 %), together with an AZA3 isomer with a lower retention time.
The identification of AZA3 was confirmed using high resolution HCD MS (Figure 7).
The heat lability of AZAl7 was observed in a previous study when mussel tissue
homogenates, containing multiple AZAs analogues, were heated to 80 °C. The
AZAl7 content declined with an observed increase in AZA3 that was much greater
than 100 % [14].
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3.4.

Xenohiotic Transformation In Bivalve Mollus

Lipophilic organic compounds are readily bioaccumulated by mollusks (geyer 1982)
and sessile species, such as the M. edulis, are widely used in so-called ‘mussel watch
pollution monitoring’ programs [15], A cytochrome P-450 mediated mixed function
oxygenase (MFO) system is present in Mytilus spp. in activities comparable to those
of other marine invertebrates [16]. These cytochrome P-450s are primarily located in
the microsomal fraction of the HP of M. edulis [17-18]. Studies using both M edulis
and its HP microsomes, have shown that organic substrates, such as benzo[a]pyrene,
produce metabolites that consist mainly of hydroxylic and ketonic compounds [16].

Hydroxylation and oxidation of other polyether cyclic toxins in shellfish have been
previously observed. For example, the conversion of yessotoxin (YTX) to 45hydroxy-yessotoxin occurs in the Japanese scallop {Patinopecten yessoensis) [19].
Pectenotoxin-2 (PTX2) undergoes bioconversion in P. yessoensis that involves
hydroxylation and oxidation of a methyl moiety to a carboxylic acid (PTX6) but
decarboxylation has not been observed (Supplementary Figure 8) [20].
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Supplementary Figure 8. Biotransformation scheme of pectenotoxin-2 (PTX2) to
PTX6 in Japanese scallop (Patinopectin yessoyensis), involving hydroxylation and
oxidation of a methyl substituent to carboxylic acid.
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is

involved

in

several

key

steps

in

sterol

biotransformations (e.g. lanosterol) to form carbon dioxide from methyl groups on
several positions of the carbon skeleton [20]. However, oxidative C-demethylation is
not a common process in xenobiotic metabolism but examples of C-demethylation in
mammal liver preparations include drug candidates, aplidine [21] and LC15-0133 [22]
(Supplementary Figure 9) As far as we are aware, the formation of AZA3 from AZA1
in

mussels,

involving

a C-demethylation,

is

an

unprecedented

xenobiotic

bioconversion in shellfish.
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Supplementary^ Figure 9. Proposed scheme for the C-demethylation of the drug
candidate, LCl 5-0133, in rat hepatocytes, adapted from Yoo et ah, [22].

4.

Conclusions

This study demonstrates for the first time a remarkable C-demethylation
bitransformation intermediate step for AZAl to AZA3 via AZA17 in the common
blue mussel (M. edulis). The results generated from this work have also provided the
first confirmation that AZA4 and AZA5 are biotransformation products of AZAl in
M. edulis. From the results it is also reasonable to conclude that C-demethylation of
azaspiracids in M. edulis is a more facile process than hydroxylation since the
concentrations levels of AZA3 and AZAl7 were consistently much higher than the
hydroxylated AZA analogues in all mussel tissues. Overall the aim of this study was
met, in that the bioconversion of AZAl to AZA3 via AZA 17 was observed as can be
seen from the above set of results.
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5.

Possible Future Work

As it is now understood that AZAl undergoes bioconversion; it would be desirable to
understand what is causing this metabolic activity. We believe this to be due to a
phase 1 enzymatic reaction involving the cytochrome P450 (CYP 450) family of
enzymes (xenobiotic metabolism). This could be demonstrated in three ways;

1) Blank (depurated) mussels would be fed isolated AZA of choice and during the
feeding experiment, inhibitors and/or inducers of the different CYP 450 enzymes
(largely CYP lAl) would be added to the tank and this would demonstrate that the
bioconversion is as a direct result of CYP 450 activity. Mussel HP which are enriched
with microsomes that contain the CYP’s believed responsible for the bioconversion of
AZA would be spun out and isolated through centrifugal force. These pellets would
then be subject to analysis by separation techniques such as one or two dimensional
sodium dodecyul sulphate, polly archrilimide gell electrophoresis (1 or 2D-SDSPAGE) followed by the excision of the various bands and there digestion with
sequential analysis by LTQ XL and QqQ mass spectrometry to determine the
resulting bioconversion products.

2) Again as mentioned in point one; isolate the microsomal fraction from the mussel
HP (blank mussels) and directly incubate with isolated AZA of choice. This is a much
quicker technique than point one and should be carried out first as it will determine if
the microsomal pellet is indeed involved in the biotransformation of AZAs. Analysis
by QqQ mass spectrometry will quickly determine if bioconversion is taken place. If

so, then it would be viable to proceed with point one.
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3) Synthetic human liver CYP 450 can also be purchased; this is a mixture that
contains nine of the most abundant CYP’s within the human liver. If blank
microsomal pellets were not an option this reaction mixture could be tested. Firstly,
the mixture is free from any AZA which would instil confidence immediately that any
bioconversion taken place is definitely CYP mediated. Secondly, there is a 95%
homology between mussel cytochromes and human cytochromes which increases the
possibility that the bioconversion will take place.

This very same future work can be included exactly as mentioned for AZA2 (chapter
IV) as both AZA I and AZA2 are governed by some form of an enzymatic metabolic
process.

6.

Materials and Methods

6.1.

Solvents and Toxin Standards

Formic acid (FA) was purchased from Sigma-Aldrich (Dublin, Ireland) and HPLCgrade acetonitrile and water were purchased from Labscan (Dublin, Ireland). Toxic
mussels (M edulis) were collected from the northwest coast of Ireland and using
procedures previously developed (Ofuji et al., 1999), allowed for isolation of AZAs,
AZAl, AZA2, AZAS and AZA6, which were confirmed using authentic standard
toxins that were kindly provided by Prof M. Satake, Tohoku University, Sendai,
Japan. Calibration studies were performed from an AZAl certified reference material
CRM-AZAl (1.24 ± 0.07 pg/ml; NRC, Halifax, Canada). Thank’s to Dr. Keith
O’Callaghan for supplying AZA isolate material to perform these studies.
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6.2.

Mussels Acclimation

One hundred and twenty mussels (M

edulis) were collected from Passage east,

county Waterford and acclimated to laboratory conditions for 14 days. During this
period, mussels were kept in two 100 1 PVC containing 60 1 of sea water, maintained
at 14 ± 0.5 °C, with constant aeration, under low light intensity exposure. Water was
replaced at 20 % every day and dead animals were removed within a 12 hour period.

6.3.

Feeding Experiments

For feeding experiments, 10 mussels were placed in each of two experimental 20 1
glass tanks, containing 1 1 per animal of sea water at 14 °C and supplemented with
shellfish diet 1800, a mixed diet of Isochiysis Pavlova, Thalassiosira weissfloii,
Tetraselmis

sp,

which

was

administered

in

accordance

with

company’s

recommendations (Reed Mariculture inc) An aliquot (50 mL) of tank water was
removed for toxin analysis every hour over a 12 hour period for estimating the levels
of toxin uptake and clearance and once again at 24 hour before conducting the 100 %
water change. Isolated AZAl was administered every day at 3 pg over a ten day
period. On day ten, six mussels were removed and opened, rinised in Mili-Q water
and weighed.

The shellfish were dissected into three compartments (HP, Gills and rest of tissue);
toxin was extracted immediately to avoid frozen storage which is thought to result in
cell wall break down and toxin distribution. A 100% water change was carried out
and the tank was replaced with four litres of fresh sea water every 24 hours for the
remaining three days. The four remaining mussels (without toxin) remained
depurating during this period and the idea here was to show if there was any
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difference between the rate of bioconversion from the first six shellfish removed after
ten days and the final four shellfish removed after thirteen days. During the exposure
period dead animals were always removed if necessary within a 12 hour period.
Aliquots (50 ml) were also taken from the experimental tank for toxin analysis and for
estimating the levels of toxin clearance.

6.4.

Toxin Extraction front Mussels

Mussel tissue (M. edulis) was divided into HP, gills and remaining tissue and were
analysed separately. Shellfish tissue was combined with acetone (4 ml) in a 50 ml
centrifuge tube and homogenised (Ultra Turrax, IKA, Germany) for 1 min followed
by centrifugation at 3000 rpm (700 g) for 3 min. The supernatant was transferred to a
centrifuge tube (50 ml), the extraction procedure was repeated on the residue and the
supernatant again combined with the above to give a final volume of 8 ml’s acetone.
A 3 ml aliquot was evaporated using nitrogen at 40 ”C to remove acetone (TurboVap,
Zymark, MA, USA). To the remaining aqueous residue, water (0.5 ml) and ethyl
acetate (2 ml) were added with vortex mixing for 1 min. The solution was centrifuged
at 700 g for 3-4 min and the ethyl acetate was transferred to a glass tube (10 ml). The
extraction with ethyl acetate (2 ml) was repeated and the combined extracts were
evaporated using nitrogen. The residue was reconstituted with acetonitrile (200 pi)
using sonication and vortex mixing and 3-5 pi of this solution were used for LC/MS
analysis.
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6.5.

Liquid Chromatography-Mass Spectrometry (LC-MS/MS)

6.5.1. Triple stage quadrupole mass spectrometer
An API 3000 (Applied Biosystems, Warrington, UK) mass spectrometer (triple stage
quadrupole) with a Turbo lonspray Interface operating in positive mode coupled to an
Agilent 1100 series HPLC system (Agilent, Palo Alto, CA, USA) was used for
analysis of AZAs. The software used was analyst 1.5 for data acquisition, data
analysis and instrument control. The ion source dependant parameters were optimised
as follows: nebuliser gas 10 (arb), curtain gas 15 (arb), lonspray voltage (IS) 4250 V,
temperature (TEM) 550 “C and collision gas (CAD) was set to 5 (arb) Multiple
reaction monitoring (MRM) experiments were developed using voltages optimised for
pseudo-molecular ion production; declustering potential (DP) 60 V, focusing potential
(FP) 300 V, entrance potential (EP) 10 V, collision cell exit potential (CXP) 15 V.

Two collision energies were adopted for two transitions of AZAs that of quantitation
and confirmation (A-ring), these included for [M+H]^ —> [M+H - FfO]^ transition,
collision energy (45 V) and for the [M+H]^

[M+H - H20-A-ring]^ transition,

collision energy (70 V) which were included for AZAl to AZA12. For AZA17 and
AZA19; the two transitions used included [M+H]^

[M+H - H20-C02]^

for

quantitation at collision energy (54 V) and [M+H]^ ^ [M+H - H20-C02-A-ring]^
transition for confirmation at collision energy (80 V). Chromatographic separation
was achieved by adopting isocratic elution (acetonitrile/water (58:42) v/v containing
0.05 % formic acid) on a reversed phase column (Luna-C-18 (2), 5 pm, 150 x 2.0
mm; Phenomenex, Macclesfield, UK) at a temperature of 35 ®C. The samples were
analysed over twenty five minutes which were injected into the system at 1 pi with
the eluent flow been directed to waste for 1 min after sample injection and carried in
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mobile phase at a constant flow rate of 200 pl/min. The quantitation for AZAl,
AZA2, AZA3 and AZA6 was obtained by the use of a certified standard, CRM-AZAl
(1.24 ± 0.07 pg/ml; NRC, Halifax, Canada).

6.5.2.

LTQ Orbitrap XL Mass Spectrometer

High mass accuracy was determined by use of an LTQ Orbitrap XL. Isocratic elution
(acetonitrile/water (58:42) v/v containing 0.05 % TFA + 1 mM NH4OAC) was
achieved on a reversed phase column (Luna-C-18 (2), 5 pm, 150 x 2.0 mm;
Phenomenex, Macclesfield, UK). The run time was fifteen minutes and samples were
injected at a final volume of 5 pi at a flow rate of 200 pl/min. High mass accuracy
spectra was acquired through higher energy collisionally activated dissociation (HCD)
in fourier transformer mass spectroscopy (FTMS) mode. For quantification, AZAs
were quantified against a certified reference standard, CRM-AZAl (1.24 ± 0.07
pg/ml; NRC, Halifax, Canada).
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CHAPTER IV

Biotransformation Studies of Azaspiracid-2 in Blue Mussel
{Mytiliis edulis)
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1.

Objective

The aim of the work was to establish the biotransformation products of azaspiracid-2
performed in vivo in mussels (M. ednlis). It was found that biotransformation
pathways of azaspiracid-2 to azaspiracid-6 follow the same mechanism that has been
proposed in chapter three for AZAl. Additionally, it provides information key to the
understanding of AZA analogue formation and highlights how chemical studies can
produce valuable information on the complex metabolic processes that marine
bioactives undergo in shellfish.
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2.

Introduction

Although azaspiracid-1 (AZAl), is the most predominant analogue of all, azaspiracid2 (AZA2) and azaspiracid-3 (AZA3), have been reported to be more toxic than AZAl
[1] with widespread organ damage affecting the liver, small intestine and spleen. This
makes the occurrence of AZA2 in shellfish as important as AZAl, and thus diserves
to be studied with equal care. These studies were conducted following the previous
study of AZAl biotransformation pathways in mussels (M ediilis) described in
chapter III. Again, feeding experiments were conducted in a very similar manner to
AZAl (see section 6 materials and methods), but with two main differences; 1) AZA2
was administered only, and 2) the shellfish were not dissected into individual
compartments.

The process of AZA2 biotransformation is again believed to be enzyme mediated and
also to follow the same enzyme mediation as that of AZAl involving cytochrome
P450 activity. A recent study of a freshwater cyanobacterium identified a novel
anatoxin derivative,

11-carboxyanatoxin-a, and found that sample preparation

procedures could result in enzymatic decarboxylation to form anatoxin-a [2]. Since
AZAl 7 is 22-carboxy-AZA3, produced by oxidative metabolism of the 22-methyl of
AZAl in the mussel, this also predicted that the levels of AZA6 would also increase
through an equivalent series of transformations via AZAl9 and was the basis of
isolating AZA2 and administering this to live shellfish.

In certain European countries, there has been shown that the typical profile in raw
mussels is being dominated by AZAl, with lesser amounts of AZA2 and with only
small amounts of AZA3. Recent reports of AZAs in southern Europe [3] and in
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northwest Africa [4] have shown a different profile. In AZA-contaminated mussels
from these regions, AZK2 is dominant followed by AZAl with only traces of AZA3,
if detected at all. This may indicate different strains of the AZA-producing organism
in varying geographical regions such as with the Norwegian mussels where AZA6 has
been observed as a significant component [5]. Recently the isolation of AZA2 was
carried out on the marine sponge Echinoclathria sp. and identified as a potent
cytotoxin [6]. \ZA2 shows no UV absorption maxima above 210 nm and therefore is
very difficult to analyse by HPLC [7].

It has been shown that AZA2 exhibits potent cytotoxicity against P388 murine
leukemia cells with an IC50 value of 0.72 ng/ml [6]. After exposure of 0.2 mg of
AZA2 for 24 hours, cell divisions were noted to be inhibited, and after 72 hours,
cytotoxicity was observed. However, AZA2 did not show any cytotoxicity against
HeLa human cervical cancer cells at the concentration of 2.0 mg/mL. In order to
analyze the effect of AZA2 on cell cycle in P388 cells, flow cytometric analysis was
conducted. The number of cells was clearly reduced in dose-dependent manner and no
change was observed in the overall population of cells. Instead AZA2 caused
dosedependent S phase arrest. Sponge derived compounds, such as tedanolide C [8]
and phorboxazole A [9], also cause S phase arrest. AZA2 was reported to affect actin
cytoskeleton arrangement [10], which is likely to induce polyploidy cells [11]. It
should be noted that AZA poisoning has been reported in Japanese shellfish, therefore
the presence of AZA2 in the sponge Echinoclathria is an interesting finding [6].

To the best of our knowledge, this is the first report of AZA2 been administered to
live mussels (M Edulis) under controlled conditions. The following work presented
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below describes how KLPsl isolate was administered, shellfish extracts analysed and
the resulting biotransformation that had taken place.

3.

Results and Discussion

In view of the below results, we propose that the most likely explanation for the
observed conversion to AZA6 upon administration of AZA2 was the presence of a
thermally labile AZA6 precursor in the shellfish and their extracts, and was observed
that AZA2 undergoes C-demethylation in position C22 producing AZA19. LC-MS
analyses were run for AZA1-AZA3 and AZA6 as in the normal routine method, but
additional MS traces were run for AZA 17 and AZA 19 (Table 1).

Toxin

IM+Hf

AZAl
AZA2
AZAS
AZA4
AZAS
AZA6
AZA7
AZAS
AZA9
AZA 10
AZAll
AZAl 2
AZAl 7
AZA 19

842.5
856.5
828.5
844.5
844.5
842.5
858.5
858.5
858.5
858.5
872.5
872.5
872.5
886.5

IM+HH20t

IM+H-H2OC02t

IM+H-H2OA-ringf

IM+H-H2OCOrAringf

672.4
672.4
658.4
658.4
674.4
658.4
672.4
688.4
658.4
674.4
672.4
688.4

824.5
838.5
810.5
826.5
826.5
824.5
840.5
840.5
840.5
840.5
854.5
854.5
810.5

824.5

658.4
658.4

Table 1. Precursor and product ions selectedfor the determination of AZAs using
MRM mass spectrometry analysis.

The studies reported here show that AZA6 is formed by the decarboxylation of
AZA 19, respectively. This implies that the carboxy-AZAs are metabolites of AZAl
and AZA2 formed by oxidation of the 22-methyl group.
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3.L

AZA2 Feeding Experiments

A total of seven mussels were used for the study which was conducted over a ten day
period. A final mass of 25.5 pg of AZA2 was administered to the seven mussels over
a seven day period (3.4 pg/day) with a 100 % water change per day. On day seven,
four mussels were removed, opened and dissected, while the remaining three mussels
were left to depurate (assisted with food and no toxin) for another three days at 100 %
water change per day in order to see a difference if any in the bioconversion rate from
the first four mussels (Figure 1). There were no observed differences in the rate of
bioconversion and more time may have been needed for extended depuration to see
any notable change in the bioconversion process. The mussels were dissected whole
and not into individual compartments i.e. HP, gills and remaining tissue.

Bocon\/ersion of FZP2. for Seven Days in far Mussels

35
30
25
20
15
10

□ Boconversion of AZ^2

/\
/\

^

5

1 ■i
AZA1

P7P2

AZA6

AZA3

AZM7

O/'
AZM9 AZA9,10

Figure 1. Barchart showing the distribution of AZAl, AZA2, AZA3, AZA6 AZA9 10, AZAZ17 and AZAl 9 in the whole tissue after feeding AZA2 to four mussels (M.
edulis).
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The tissue was in a very poor state and virtually impossible to dissect, which may
have been as a result of the severe toxicity of AZA2 which is more toxic than AZAl
and AZA3 [12] (Figure 2).

A)

B)

Figure 2. A) Non toxic mussel (M. edulis) and B) Toxic mussel (M. edulis) after
AZAl was administered.
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This decision to dissect whole and not into individual compartments was a result of
the tissue been too far damaged after administering AZA2 and there been insufficient
AZA2 available to repeat the study with a greater number of shellfish. Positive
observation of biotransformation for AZA2 to AZA6 via AZA19 (Figure 3) was the
main issue here. Distribution to other tissue compartments to monitor profiling would
have been desirable but can be studied when more AZA2 becomes available. A feed
study (AZA1-AZA3 and AZA6) was conducted, in which shellfish were dissected
into HP, gills and rest of tissue, which confirmed that AZA2 was infact distributing to
different tissue compartments.

I

KPO.

yeA3
\
\

AZM7

\

AZ^-IO

r

—r

7M

^
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1U

17J

'sr

StJI

BLM

Figure 3. Sample chromatogram showing the AZA composition in mussel (M.
edulis) after feeding AZA2.
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From the 25.5 fig of pure AZA2 administered to the mussels, 11.7 fig of total AZA
was recovered from the whole tissue. The water was sampled over a 12 hour period
(50 ml/h) to monitor uptake of AZA from water to mussels and could be seen that
after seven hours virtually all AZA2 (> 97 %) was consumed. Before the 100 % water
change after 24 hours, aliquots (50 ml) were again sampled for AZA analysis and a
total of 5.2 fig was quantified by solid phase clean up [13] with analysis by LCMS/MS using triple quadrupole API 3000. All orbitrap MS/MS work was kindly
conducted by Zuzana Skrabakova in PROTEOBIO.

Over the seven days, a total of 20.2 fig AZA2 was taken up by the shellfish, with 5.2
fig remaining in the tank. After shellfish were analysed for AZAs the recovery was
11.7 fig total AZA in tissues and 5.2 fig in water, giving a total of 16.9 fig AZAs
recovered. This leaves 8.6 fig AZA that has not been accounted for in shellfish tissue
and water. It seems that AZA2 is undergoing some other forms of metabolic activity
and is therefore an important determinant of the activity of the toxin. It was observed
that AZA2 undergoes C-demethylation in position C22 producing AZA 19 (Figure 4),
similar to AZA 1 bioconverting to AZA 17.
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The presence of AZAl suggests that the C-demethylation occurs on position 8 as well
(double demethylation), however the demethylation in position 22 is prevalent, as can
be seen from the abundance of AZA6 compared to AZAl (Figure 1 and 3). We
assume that this follows the same mechanism and a carboxy intermediate AZAl8 is
being produced prior the loss of CO2 and consequent formation of AZAl from AZA2.
Since the mass of AZAl8 is the same as the mass of its isomer AZAl9, the HCD
spectra for AZAl9 were checked for a presence of A-ring loss of a value 672.4 m/z
(Table 1), which is a transition which would have been observed for the presence of
AZAl8. This transition (672.4 m/z) was not observed probably due to its very low
abundance, as the percentage of AZAl was also very low (1.9%) over the ten day
study. As a result of the formation of AZAl, we would expect this to undergo Cdemethylation to form AZAl7 followed by decarboxylation to form AZA3 and as can
be seen from figure 3 this was the observed result. The production of AZA6 (Figure
5) also gave rise to resulting hydroxylate analogues AZA9 and AZAIO (Figure 3), as
a result of hydroxylation of AZA6 in the

position to yield AZA9 and in the

position to yield AZAIO (Table 2).

Toxin

r'

AZAl

H”

R^

CH3

H

H

AZA2

CH3

CH3

H

H

AZA3

H

H

H

H

AZA6

H

CH3

H

H

AZA9

OH

CH3

H

H

AZAIO

H

CH3

H

OH

AZA17

H

COOH

H

H

AZAl 9

H

COOH

H

H

Table 2. Designation of azaspiracid substituents, R\ R~, R^ and K*
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3.2.

AZA7, AZA2y AZA3 and AZA6 Feeding Experiments

The study was conducted with a total of 18 mussels and a mixture of AZAl (83.3 |xg),
AZA2 (25.0

|Lig),

AZA3 (1.1 gg) and AZA6 (0.01 gg) was administered as a single

dose with the aim of monitoring AZA bioconversion and distribution among three
compartments within the mussel, HP, gills and rest of tissue. From the findings it was
observed that the level of AZA3 and AZA6 had increased from what was originally
administered, and toxin distribution in various tissue compartments had indeed taken
place. This finding supports the supposition that AZA2 is undergoing bioconversion
to AZA6 via AZA 19 and additionally supported chapter three’s findings where AZAl
underwent bioconversion to AZA3 via AZA 17.

Figure’s 6, 7 and 8 which are extracted ion chromatographic data obtained from a LC
QqQ mass spectrometer; clearly shows a distribution throughout all three mussel
compartments and an increase in the levels of AZA3 and AZA6 with AZA 17 and
AZA 19 formation. The results observed from these findings supports the AZA2
feeding study in that bioconversion is clearly taken place. Resulting hydroxylates
from AZAl and AZA2 (AZA4, AZA5, AZA9, and AZA 10) were also observed, but
at not significant values when compared with other AZAs (< 1 %).
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1D0%
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Figure 6. Sample chromatogram showing the AZA composition in the HP of mussel
(M. edulis) after feeding AZAf AZA2, AZA3 and AZA 6 mixture.

10C%

Time, min

Figure 7. Sample chromatogram showing the AZA composition in the gills of
mussels (M. Edulis) after feeding AZA I, AZA2, AZA3 and AZA6 mixture.
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Figure 8. Sample chromatogram showing the AZA composition in the rest of tissue
of mussels (M. Edulis) after feeding AZA I, AZA2, AZA3 and AZA6 mixture.
The above chromatograms (Figures 6, 7, and 8) clearly show that there is a significant
increase in the levels of AZA6 in all three compartments (HP, gills and rest of tissue)
when compared to AZAl which is normally the most abundant toxin of all. As a
result of the increase in AZA6 there was an observed decrease in the levels of AZA2,
which is as a result of demethylation producing greater mass (pg/g) of AZA6
extracted from the tissue then was initially present. The same was observed for AZAl
in all three compartments, the levels of AZA3 far exceeded the levels of AZAl which
was as a result of demethylation through AZAl, resulting again in a greater mass
(pg/g) of AZA3 extracted then what was initially present. Overall it was by a process
of double demethylation resulting in the above significant profile. From the above
findings we hypothesized that AZAl and AZA2 were indeed undergoing some form
of biotransformation which resulted in the observed elevated levels of AZA3 and
AZA6 through the decarboxylation of AZA 17 and AZA 19.
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4.

Conclusions

The aim of the work was to establish the biotransformation products of AZA2
performed in vivo in mussels (M. edulis). As can be seen from the results obtained
this was clearly the case. \ZA2 was indeed undergoing bioconversion to AZA6 via
an intermediate caboxylated AZA19. The unexpected result of AZAl, AZA17 and
AZA3 (which is believed to be as a result of double demethylation) will need to be
investigated further when more AZA2 isolate becomes available and further feeding
studies can be conducted. Overall the aim of the experiment was a success in that
depurated mussels were administered pure isolated AZA2 and the resulting
biotransformation of AZA2 to AZA6 via AZAl9 was observed as can be seen from
the above set of results.

5.

Possible Future Work

Future work that can be conducted would be the same as that for AZAl. We believe
that this biotransformation is enzyme mediated and so to establish what enzymes are
responsible for the process would be desirable. Also, as with AZAl7, AZAl9 should
be isolated from shellfish and a heating study performed to show that the production
of AZA 6 is due to the thermally liable AZAl9 undergoing decarboxylation.

6.

Materials and Methods

6.1.

Toxin Standards and Chemicals

HPLC grade acetonitrile and water were purchased from Labscan (Dublin, Ireland)
and formic acid from Sigma-Aldrich (Dublin, Ireland). Azaspiracids, AZAl, AZA2,
AZA3 and AZA6, were isolated from mussels (M edulis) that were collected from
northwest Ireland, using procedures previously described [14] and confirmed using
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authentic standard toxins kindly provided by Prof. M. Satake, Tohoku University,
Sendai, Japan. The quantitation for AZAl, AZA2, AZA3 and AZA6 was obtained by
the use of a certified standard, CRM-AZAl (1.24 ± 0.07 |.ig/ml; NRC, Halifax,
Canada). Thank’s to Dr. Keith O’Callaghan for supplying AZA isolate material to
perform these studies.

6.2.

Mussels Acclimation

Mussel acclimation was carried out for 14 days to laboratory conditions by gathering
one hundred and twenty mussels (M edulis) from Passage east, county Waterford.
Whilst in the laboratory, mussels were kept in two 100 1 PVC tanks containing 60 1 of
sea water, both tanks had a continuous supply of aeration and were kept under low
light intensity exposure while maintained at 14 ± 0.5 °C. Water quality was
maintained by performing a 20 % water change every day and any dead animals were
removed within a 12 hour period.

6.3.

Feeding Experiments

A total of seven mussels were used for the feeding experiment. The mussels were
placed into two 10 1 glass tanks, each mussel was supplied with one liter per animal of
fresh sea water and supplemented with shellfish diet 1800, a mixed diet of Isochrysis
Pavlova, Thalassiosira weissfloii, Tetraselmis sp which was administered in
accordance with company’s recommendations (Reed Mariculture inc). The feeding
experiment involved the addition of isolated AZA2 which was administered at a final
dose of 3.4 pg/day. AZA2 isolate was fed to the shellfish over seven days (25.5 pg)
with a 100 % water change at the end of each day (after 24 hours). In order to monitor
and estimate the levels of toxin uptake and clearance aliquots of 50 ml were collected
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every hour over a 12 hour period to monitor uptake and once again at 24 hour to
estimate clearance (50 ml). During the exposure period any dead animals were always
removed within a 12 hour period. On the seventh day of the experiment four mussels
were removed and opened, rinised in Mili-Q water and weighed. The toxin was
extracted immediately from the individually dissected three compartments (HP, Gills
and remaining tissue) in order to eliminate the possibility of cell wall break down and
toxin distribution that may occur from frozen storage. For the remainder of the
feeding experiment, the remaining three shellfish were replaced with 100 % fresh
water each day for the next three days and supplemented with shellfish diet instant
algae. On day 13, these three shellfish were dissected into there individual
compartments and the toxin extracted im.mediately.

6.4.

Toxin Extraction from Mussels

Mussel whole tissue (M. edulis) was analysed individually. Shellfish tissue was
combined with acetone (4 ml) in a 50 ml centrifuge tube and homogenised (Ultra
Turrax, IKA, Germany) for 1 min followed by centrifugation at 3000 rpm (700 g) for
3 min. The supernatant was transferred to a centrifuge tube (50 ml), the extraction
procedure was repeated on the residue and the supernatant was transferred to the
centrifuge tube to give a total of 8 ml acetone. A 3 ml aliquot was evaporated using
nitrogen at 40

to remove acetone (TurboVap, Zymark, MA, USA). To the

remaining aqueous residue, water (0.5 ml) and ethyl acetate (2 ml) were added with
vortex mixing for 1 min. The solution was centrifuged at 700 g for 3-4 min and the
ethyl acetate was transferred to a glass tube (10 ml). The extraction with ethyl acetate
(2 ml) was repeated and the combined extracts were evaporated using nitrogen. The
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residue was reconstituted with acetonitrile (200 }il) using sonication and vortex
mixing and 3-5 gl of this solution were used for LC/MS analysis.

6.5.

Liquid Chromatography-Mass Spectrometry (LC-MS/MS)

6.5.1. Triple Stage Quadrupole Mass Spectrometer (QqQ)
An API 3000 (Applied Biosystems, Warrington, UK) mass spectrometer (triple stage
quadrupole) with a Turbo lonspray Interface operating in positive mode coupled to an
Agilent 1100 series HPLC system (Agilent, Palo Alto, CA, USA) was used for
analysis of azaspiracids. The software used was analyst 1.5 for data acquisition, data
analysis and instrument control. The ion source dependant parameters were optimised
as follows: nebuliser gas 10 (arb), curtain gas 15 (arb), lonspray voltage (IS) 4250 V,
temperature (TEM) 550 °C and collision gas (CAD) was set to 5 (arb) Multiple
reaction monitoring (MRM) experiments were developed using voltages optimised for
pseudo-molecular ion production; declustering potential (DP) 60 V, focusing potential
(FP) 300 V, entrance potential (EP) 10 V, collision cell exit potential (CXP) 15 V
(table 1). Two collision energies were adopted for two transitions of azaspiracids that
of quantitation and confirmation (A-ring), these included for [M+H]"^ ^ [M+H H20]^ transition, collision energy (45 V) and for the [M+H]^ —> [M+H - H2O-Aring]^ transition, collision energy (70 V) which were included for AZAl to AZA12.
For AZAl7 and AZAl9; the two transitions used included [M+H]^ ^ [M+H - H2OC02]^ for quantitation at collision energy (54 V) and [M+H]^ ^ [M+H - H2O-CO2A-ring]^ transition for confirmation at collision energy (80 V).

Chromatographic

separation

was

achieved

by

adopting

isocratic

elution

(acetonitrile/water (58:42) v/v containing 0.05 % formic acid) on a reversed phase
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column (Luna-C-18 (2), 5 |im, 150 x 2.0 mm; Phenomenex, Macclesfield, UK) at a
temperature of 35 °C. The samples were analysed over twenty five minutes which
were injected into the system at 1 pi with the eluent flow been directed to waste for 1
min after sample injection and carried in mobile phase at a constant flow rate of 200
pl/min,

6.5.2. LTQ Orhitrap XL Mass Spectrometer
High mass accuracy was determined by use of an LTQ Orbitrap XL. Isocratic elution
(acetonitrile/water (58:42) v/v containing 0.05 % TFA + 1 Mm NH4OAC) was
achieved on a reversed phase column (Luna-C-18 (2), 5 pm, 150 x 2.0 mm;
Phenomenex, Macclesfield, UK). The run time was fifteen minutes and samples were
injected at a final volume of 5 pi at a flow rate of 200 pl/min. High mass aecuracy
spectra was acquired through higher energy collisionally activated dissociation (HCD)
in fourier transformer mass spectroscopy (FTMS) mode. For quantification,
azaspiracids were quantified against a certified reference standard, CRM-AZAl (1.24
± 0.07 pg/ml; NRC, Halifax, Canada).
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